<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Genet</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Genet</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosgen</journal-id><journal-title-group><journal-title>PLoS Genetics</journal-title></journal-title-group><issn pub-type="ppub">1553-7390</issn><issn pub-type="epub">1553-7404</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6797082</article-id><article-id pub-id-type="doi">10.1371/journal.pgen.1008271</article-id><article-id pub-id-type="publisher-id">PGENETICS-D-18-01941</article-id><article-categories><subj-group subj-group-type="heading"><subject>Topic Page</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Replication</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Organismal Evolution</subject><subj-group><subject>Microbial Evolution</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Evolution</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Microbial Genomics</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Genomics</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Genomics</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutagenesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Evolutionary Biology</subject><subj-group><subject>Evolutionary Immunology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Microbial Mutation</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Animal Genomics</subject><subj-group><subject>Mammalian Genomics</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Viral quasispecies</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0573-1676</contrib-id><name><surname>Domingo</surname><given-names>Esteban</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Perales</surname><given-names>Celia</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Centro de Biolog&#x000ed;a Molecular Severo Ochoa (CSIC-UAM), Consejo Superior de Investigaciones Cient&#x000ed;ficas (CSIC), Campus de Cantoblanco, Madrid, Spain</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Centro de Investigaci&#x000f3;n Biom&#x000e9;dica en Red de Enfermedades Hep&#x000e1;ticas y Digestivas (CIBERehd) del Instituto de Salud Carlos III, Madrid, Spain</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>Department of Clinical Microbiology, IIS-Fundaci&#x000f3;n Jim&#x000e9;nez D&#x000ed;az, UAM, Madrid, Spain</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><corresp id="cor001">* E-mail: <email>edomingo@cbm.csic.es</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2019</year></pub-date><volume>15</volume><issue>10</issue><elocation-id>e1008271</elocation-id><permissions><copyright-statement>&#x000a9; 2019 Domingo, Perales</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Domingo, Perales</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pgen.1008271.pdf"/><abstract><p><bold>Viral quasispecies</bold> refers to a <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Population_structure">population structure</ext-link> that consists of extremely large numbers of variant <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genomes">genomes</ext-link>, termed <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Mutant_spectrum">mutant spectra</ext-link>, mutant swarms or mutant clouds. Fueled by high <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Mutation_rate">mutation rates</ext-link>, mutants arise continually, and they change in relative <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/allele_frequency">frequency</ext-link> as <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_replication">viral replication</ext-link> proceeds. The term quasispecies was adopted from a theory of the <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Origin_of_life">origin of life</ext-link> in which primitive <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Replicon_(genetics">replicons</ext-link>) consisted of mutant distributions, as found experimentally with present day <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/RNA_virus">RNA viruses</ext-link>. The theory provided a new definition of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Wild_type">wild type</ext-link>, and a conceptual framework for the interpretation of the <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Adaptive_potential">adaptive potential</ext-link> of RNA viruses that contrasted with classical studies based on <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Consensus_sequence">consensus sequences</ext-link>. Standard clonal analyses and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Deep_sequencing">deep sequencing</ext-link> methodologies have confirmed the presence of myriads of mutant genomes in viral populations, and their participation in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Adaptation">adaptive processes</ext-link>. The quasispecies concept applies to any biological entity, but its impact is more evident when the genome size is limited and the mutation rate is high. This is the case of the RNA viruses, ubiquitous in our <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Biosphere">biosphere</ext-link>, and that comprise many important <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Pathogen">pathogens</ext-link>. In <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Virology">virology</ext-link>, quasispecies are defined as complex distributions of closely related variant genomes subjected to <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genetic_variation">genetic variation</ext-link>, competition and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Natural_selection">selection</ext-link>, and that may act as a <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Unit_of_selection">unit of selection</ext-link>. Despite being an integral part of their replication, high mutation rates have an <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Error_threshold_(evolution">upper limit</ext-link> compatible with inheritable information. Crossing such a limit leads to RNA <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Extinction_vortex">virus extinction</ext-link>, a transition that is the basis of an antiviral design termed <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Lethal_mutagenesis">lethal mutagenesis</ext-link>.</p></abstract><funding-group><funding-statement>Work by ED and CP was supported by grants BFU2011-23604, SAF2014-52400-R, SAF2017-87846-R and BFU2017-91384-EXP, from the Spanish Ministerio de Econom&#x000ed;a y Competitividad (MINECO) (<ext-link ext-link-type="uri" xlink:href="http://www.mineco.gob.es">www.mineco.gob.es</ext-link>) and S2013/ABI-2906 (PLATESA from Comunidad de Madrid/FEDER) (<ext-link ext-link-type="uri" xlink:href="http://platesa-es.weebly.com">http://platesa-es.weebly.com</ext-link>). CIBERehd (Centro de Investigaci&#x000f3;n en Red de Enfermedades Hep&#x000e1;ticas y Digestivas) (<ext-link ext-link-type="uri" xlink:href="http://www.ciberisciii.es">www.ciberisciii.es</ext-link>) is funded by Instituto de Salud Carlos III. C.P. is supported by the Miguel Servet program of the Instituto de Salud Carlos III (CP14/00121) cofinanced by the European Regional Development Fund (ERDF). Institutional grants from the Fundaci&#x000f3;n Ram&#x000f3;n Areces and Banco Santander to the CBMSO are also acknowledged. The funders had no role in the preparation of the article.</funding-statement></funding-group><counts><fig-count count="4"/><table-count count="1"/><page-count count="20"/></counts></article-meta></front><body><sec id="sec001"><title>Historical origins</title><p>Quasispecies theory was developed in the 1970&#x02019;s by <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Manfred_Eigen">Manfred Eigen</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Peter_Schuster">Peter Schuster</ext-link> to explain self-organization and adaptability of primitive replicons (we use the term replicon to refer to any replicating entity), as an ingredient of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Hypercycle">hypercyclic organizations</ext-link> that link <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genotype">genotypic</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Phenotype">phenotypic</ext-link> information, as an essential step in the origin of life [<xref rid="pgen.1008271.ref001" ref-type="bibr">1</xref>,<xref rid="pgen.1008271.ref002" ref-type="bibr">2</xref>]. The theory portrayed early replicon populations as organized mutant spectra dominated by a master sequence, the one endowed with the highest <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Fitness_(biology">fitness</ext-link> (replicative capacity) in the distribution. It introduced the notion of a mutant ensemble as a unit of selection, thus emphasizing the relevance of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/intra-population_interaction">intra-population interactions</ext-link> to understand the response to <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Selective_constraint">selective constraints</ext-link>. One of its corollaries is the <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Error_threshold">error threshold</ext-link> relationship, which marks the maximum mutation rate at which the master (or dominant) sequence can stabilize the mutant ensemble. Violation of the error threshold results in loss of dominance of the master sequence and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/genetic_drift">drift</ext-link> of the population in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Sequence_space_(evolution">sequence space</ext-link>) [<xref rid="pgen.1008271.ref002" ref-type="bibr">2</xref>&#x02013;<xref rid="pgen.1008271.ref005" ref-type="bibr">5</xref>].</p><p>The core quasispecies concepts are described by two fundamental equations: replication with production of error copies, and the error threshold relationship (<xref ref-type="fig" rid="pgen.1008271.g001">Fig 1</xref>). They capture two major features of RNA viruses at the population level: the presence of a mutant spectrum, and the adverse effect of an increase of mutation rate on virus survival, each with several derivations (<xref ref-type="fig" rid="pgen.1008271.g002">Fig 2</xref>).</p><fig id="pgen.1008271.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1008271.g001</object-id><label>Fig 1</label><caption><title>Fundamental equations of quasispecies and representation of mutant spectra.</title><p>The equations are the mathematical expression of the major concepts implied by quasispecies theory. The first equation describes the change of concentration of molecule i as a function of replication parameters, and its production from other molecules of the same ensemble. The second equation is the error threshold relationship, indicating the maximum amount of information (&#x0028b;<sub>max</sub>) and the maximum average error rate p<sub>max</sub> (p = 1- q; q is the copying fidelity) for maintenance of genetic information. Terms are defined in the box on the right. Below, an evolving mutant spectrum (with mutations represented as symbols on the genomes), with an invariant consensus sequence. Details in [<xref rid="pgen.1008271.ref002" ref-type="bibr">2</xref>].</p></caption><graphic xlink:href="pgen.1008271.g001"/></fig><fig id="pgen.1008271.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1008271.g002</object-id><label>Fig 2</label><caption><title>Flow of conceptual derivations of quasispecies theory for viral populations, and some biological consequences.</title></caption><graphic xlink:href="pgen.1008271.g002"/></fig><p>The existence of a mutant spectrum was experimentally evidenced first by clonal analyses of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/RNA_bacteriophage_Q%CE%B2">RNA bacteriophage Q&#x003b2;</ext-link> populations whose replication had been initiated by a single virus particle. Individual genomes differed from the consensus sequence in an average of one to two mutations per individual genome [<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>]. Fitness of biological clones was inferior to that of the parental, uncloned population, a difference also documented for <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Vesicular_stomatitis_virus">vesicular stomatitis virus</ext-link> (VSV) [<xref rid="pgen.1008271.ref007" ref-type="bibr">7</xref>]. The <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Replicative_capacity">replicative capacity</ext-link> of a population ensemble need not coincide with that of its individual components. The finding that a viral population was essentially a pool of mutants came at a time when mutations in general genetics were considered rare events, and virologists associated a viral genome with a defined <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Nucleotide_sequence">nucleotide sequence</ext-link>, as still implied today in the contents of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Data_bank">data banks</ext-link> [<xref rid="pgen.1008271.ref008" ref-type="bibr">8</xref>]. The cloud nature of Q&#x003b2; was understood as a consequence of its high mutation rate, calculated in 10<sup>&#x02212;4</sup> mutations introduced per nucleotide copied [<xref rid="pgen.1008271.ref009" ref-type="bibr">9</xref>], together with <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/mutation_tolerance">tolerance</ext-link> of individual genomes to accept an undetermined proportion of the newly arising mutations, despite fitness costs. The error rate estimated for bacteriophage Q&#x003b2; has been confirmed, and is comparable to values calculated for other RNA viruses [<xref rid="pgen.1008271.ref010" ref-type="bibr">10</xref>,<xref rid="pgen.1008271.ref011" ref-type="bibr">11</xref>].</p><p>High mutation rates and quasispecies were verified for other RNA viruses based on dissection of viral populations by molecular or biological cloning, and sequence analysis of individual clones. John Holland and colleagues were the first to recognize that a rapidly evolving RNA world inserted in a DNA-based biosphere had multiple evolutionary and medical implications [<xref rid="pgen.1008271.ref012" ref-type="bibr">12</xref>&#x02013;<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>]. Genome plasticity of RNA viruses had been suspected for many decades. Key early observations were variations in viral traits described by Findley in the 1930&#x02019;s, the studies of Granoff on transitions of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_plaque">plaque</ext-link> morphology of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Newcastle_disease_virus">Newcastle disease virus</ext-link>, or the high frequency of conversions between <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Drug_resistance">drug resistance</ext-link> and dependence in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Coxsackie_A9_virus">Coxsackie A9 virus</ext-link>, among other studies with animal and plant viruses in the middle of the 20<sup>th</sup> century (for a historical overview and references, see 15). When put in the context of present day knowledge, we realize that these observations on phenotypic changes were the tip of the iceberg of an extremely complex reality of viral populations. High mutation rates and population heterogeneity characterize RNA viruses, with consequences for viral pathogenesis and the control of viral disease. Detailed studies on quasispecies dynamics <italic>in vivo</italic> have been performed with <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Human_immunodeficiency_virus_type_1">human immunodeficiency virus type 1</ext-link> (HIV-1) and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Hepatitis_C_virus">hepatitis C virus</ext-link> [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pgen.1008271.ref018" ref-type="bibr">18</xref>].</p><sec id="sec002"><title>Current scope of quasispecies</title><p>The first mathematical formulation of quasispecies was deterministic; it assumed steady state mutant distributions in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Equilibrium">equilibrium</ext-link> without perturbations derived from modifications of the environment or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Population_size">population size</ext-link> [<xref rid="pgen.1008271.ref002" ref-type="bibr">2</xref>]. These conditions are common in initial theoretical formulations of complex phenomena because they confer mathematical tractability. Since then, several extensions of the theory to non-equilibrium conditions with stochastic components have been developed, with the aim of finding general solutions for multi-peak <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/fitness_landscape">fitness landscapes</ext-link>. These objectives approximate quasispecies to the real case of RNA viruses, which are compelled to deal with dramatic variations in population size and environment (reviewed in [<xref rid="pgen.1008271.ref019" ref-type="bibr">19</xref>]). Research on quasispecies has proceeded through several theoretical and experimental avenues that include continuing studies on evolutionary optimization and the origin of life, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/RNA-RNA_interactions">RNA-RNA interactions</ext-link> and replicator networks, the error threshold in variable fitness landscapes, consideration of chemical mutagenesis and proofreading mechanisms, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Somatic_evolution_in_cancer">evolution of tumor cells</ext-link>, bacterial populations or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Stem_cell">stem cells</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Chromosomal_instability">chromosomal instability</ext-link>, drug resistance, and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Protein_dynamics">conformation distributions</ext-link> in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Prions">prions</ext-link> (a class of proteins with conformation-dependent pathogenic potential; in this case the quasispecies is defined by a distribution of conformations) [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>]. New inputs into experimental quasispecies research have come from deep sequencing to probe viral and cellular populations, recognition of interactions within mutant spectra, models of viral <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Population_dynamics">population dynamics</ext-link> related to disease progression and pathogen transmission, and new teachings from fidelity variants of viruses (the several theoretical, experimental and practical facets of quasispecies have been reviewed in several chapters of [<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>]). Here we summarize the main aspects of quasispecies dynamics, and recent developments relevant to virus evolution and pathogenesis.</p></sec></sec><sec id="sec003"><title>Dynamic heterogeneity</title><p>The molecular basis of high error rates is the limited template-copying fidelity of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/RNA-dependent_RNA_polymerase">RNA-dependent RNA polymerases</ext-link> (RdRps) and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/RNA-dependent_DNA_polymerases">RNA-dependent DNA polymerases</ext-link> (also termed reverse transcriptases, RTs). In addition, these enzymes are defective in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Proofreading_(biology">proofreading</ext-link>) [<xref rid="pgen.1008271.ref021" ref-type="bibr">21</xref>] because they lack a 3&#x02019; to 5&#x02019; <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Exonuclease">exonuclease</ext-link> domain present in replicative cellular DNA polymerases [<xref rid="pgen.1008271.ref022" ref-type="bibr">22</xref>]. Also, postreplicative-repair pathways, abundant to correct genetic lesions in replicating cellular DNA, appear as ineffective for double-stranded RNA or RNA-DNA hybrids. The presence of a proofreading-repair activity in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Coronavirus">coronaviruses</ext-link> increases their copying accuracy in about 15-fold [<xref rid="pgen.1008271.ref023" ref-type="bibr">23</xref>]. This and other repair activities, that may act on standard RNA or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Retrovirus">retroviral</ext-link> genomes [<xref rid="pgen.1008271.ref024" ref-type="bibr">24</xref>&#x02013;<xref rid="pgen.1008271.ref027" ref-type="bibr">27</xref>], do not prevent the formation of mutant spectra, although their amplitude may be lower than for other RNA viruses, at least in populations close to a clonal (single genome) origin. Quasispecies dynamics will operate in any viral or cellular system in which due to high mutation rates (as a result of low fidelity nucleic acid polymerases or environmental alterations) mutant spectra are rapidly generated [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref028" ref-type="bibr">28</xref>&#x02013;<xref rid="pgen.1008271.ref032" ref-type="bibr">32</xref>].</p><p>Studies with different <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Host%E2%80%93pathogen_interaction">virus-host systems</ext-link> have established some general observations on the mechanisms of mutant generation, and implications of quasispecies dynamics [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>,<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pgen.1008271.ref041" ref-type="bibr">41</xref>]. In RNA virus genetics when we speak of &#x0201c;a mutant&#x0201d; the entity we handle is a cloud of mutants in which the specific mutation to which we direct our attention is present in all (or the great majority of) individual genomes. There is no such a thing as &#x0201c;a&#x0201d; wild type or &#x0201c;a&#x0201d; mutant virus. They are always clouds of mutants. Changes in the relative dominance of components of mutant spectra are particularly severe during <italic>in vivo</italic>
<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/viral_infection">infections</ext-link>, with complex dynamics of intra-host heterogeneity and variations. <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Bioinformatics">Bioinformatic</ext-link> procedures have been developed to unveil the relationships among different but closely related genome types that may suggest some hierarchical order of mutation acquisition or identification of transmission clusters (examples are <bold>P</bold>artition <bold>A</bold>nalysis of <bold>Q</bold>uasispecies, PAQ [<xref rid="pgen.1008271.ref042" ref-type="bibr">42</xref>] or <bold>QU</bold>asispecies <bold>E</bold>volution, <bold>N</bold>etwork-based <bold>T</bold>ransmission <bold>In</bold>ference, QUENTIN [<xref rid="pgen.1008271.ref043" ref-type="bibr">43</xref>]).</p><sec id="sec004"><title>Phenotypic reservoirs</title><p>The crux of the matter regarding quasispecies implications is that at any given time, the viral population includes a reservoir not only of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genotype">genotypic</ext-link> but also of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Phenotype">phenotypic</ext-link> variants, conferring upon the population some adaptive <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Pluripotency">pluripotency</ext-link>. Accumulating laboratory and clinical evidence renders untenable that minority components of mutant spectra should be dismissed on the grounds of their being <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Neutral_mutation">neutral</ext-link>. They can participate in selective processes and cannot be excluded from interpretations of virus behavior. Variation universally involves <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Point_mutation">point mutations</ext-link> and it can also include <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genetic_recombination">recombination</ext-link> (in its replicative and non-replicative modes), and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Genome_segment_reassortment">genome segment reassortment</ext-link> [<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>]. All modes of molecular variation are compatible, only restricted by the scope of mechanisms accessible to the replicative machinery, and for the need of viral genomes to remain functional. David Evans and colleagues identified many recombination events associated with <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Enterovirus">enterovirus</ext-link> replication, and only a few recombinants made their way towards continued replication [<xref rid="pgen.1008271.ref044" ref-type="bibr">44</xref>]. Recombination can mediate adaptability and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Virulence">virulence</ext-link> [<xref rid="pgen.1008271.ref045" ref-type="bibr">45</xref>]. High mutation and recombination rates have led to the conceptual distinction between mechanistically unavoidable and evolutionarily relevant variation, in connection with the issue of clonal versus non-clonal nature of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Virus_evolution">virus evolution</ext-link> (microbial evolution in general) [<xref rid="pgen.1008271.ref046" ref-type="bibr">46</xref>,<xref rid="pgen.1008271.ref047" ref-type="bibr">47</xref>]. Only a minority of the nascent variation during replication can be successfully propagated. Within limits that are set by <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Biological_constraint">biological constraints</ext-link>, each population is made of an array of variant genomes, with a total number which is commensurate with the virus population size. To infect a plant, animal or cell culture with 10<sup>3</sup> infectious units can have very different consequences than to infect with 10<sup>10</sup> infectious units, not only because the <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Host_defense">host defense</ext-link> systems may be overwhelmed by the high infectious dose, but also because the mutant repertoire that engages in adaptive explorations is larger. Part of the variants of a mutant spectrum, either in isolation or in consortium with others [<xref rid="pgen.1008271.ref048" ref-type="bibr">48</xref>], may perform better than other members of the same population in the event of an environmental change. Selective pressures favor replication of some components of a mutant spectrum over others, despite all of them being interconnected by mutation. Differential performance can be at the level of viral genomes (during replication, intracellular <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Gene_expression">gene expression</ext-link>, interaction with host factors, etc.) or viral particles (for thermal stability, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_entry">entry into</ext-link> or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_shedding">exit from</ext-link> cells, to withstand neutralizing antibodies, etc.) [<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>,<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>&#x02013;<xref rid="pgen.1008271.ref018" ref-type="bibr">18</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>,<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>].</p><p>Adaptability of RNA viruses is linked to parameters that facilitate exploration of sequence space: genome size (1.8 to 33 Kb), population size (variable but that can attain an impressive 10<sup>12</sup> individual genomes in an infected host at a given time), replication rate, mutation rate, fecundity (yield of viral particles per cell), and number of mutations required for a phenotypic change (surprisingly low for several relevant traits) (see [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]).</p><p>Mutant spectrum dynamics has been depicted in different ways, and we have chosen one that encompasses frequent events in natural populations and research designs, such as <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Virus_isolation">virus isolation</ext-link> from an infected host, adaptation to cell culture for studies on experimental evolution, or adaptation to alternative hosts in vivo (<xref ref-type="fig" rid="pgen.1008271.g003">Fig 3</xref>). Despite the complexity conveyed by the figure, the reality is even more complex, given the large population sizes, with an indeterminate proportion of genomes actively replicating at any given time (sometimes equated with the effective population size in general genetics), and harboring multiple mutations per genome. The scenarios suggested by current experimental data defy our imagination. The relative frequency of individual mutations fluctuates in an unceasing exploration of sequence space [<xref rid="pgen.1008271.ref050" ref-type="bibr">50</xref>&#x02013;<xref rid="pgen.1008271.ref052" ref-type="bibr">52</xref>], with phenotypic changes (not only genotypic changes) being far more frequent than previously thought. The <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Experimental_evolution">experimental evolution</ext-link> design that consists of passaging viral populations for long time periods (many sequential infections) is often extremely revealing. In <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Foot-and-mouth_disease_virus">foot-and-mouth disease virus</ext-link> (FMDV) such a design led to a remarkable phenotypic diversification into subpopulations of colonizers and competitors, that modulated virulence of the mutant ensemble [<xref rid="pgen.1008271.ref053" ref-type="bibr">53</xref>]. In HCV such a design unveiled continuous mutation waves and a more accurate understanding of the types of fitness landscapes occupied by high fitness viruses [<xref rid="pgen.1008271.ref051" ref-type="bibr">51</xref>,<xref rid="pgen.1008271.ref054" ref-type="bibr">54</xref>].</p><fig id="pgen.1008271.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1008271.g003</object-id><label>Fig 3</label><caption><title>Scope of viral population dynamics.</title><p>Upon isolation from an infected host (middle boxes), a virus sample may be adapted to cultured cells and subjected to large population or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Population_bottleneck">bottleneck transfers</ext-link> (left box), or be adapted to a different host <italic>in vivo</italic> (right box). Relevant adaptive mutations are highlighted with colored symbols.</p></caption><graphic xlink:href="pgen.1008271.g003"/></fig></sec><sec id="sec005"><title>Limitations and indeterminacies</title><p>The nucleotide sequence of an individual genome from a population (no matter which the degree of population complexity might be), can be determined either following a biological or molecular cloning event or by deep sequencing of entire viral genomes, in a manner that mutation linkage (assignment of different mutations to the same genome molecule) can be established. Each of these procedures implies some limitations: biological cloning can bias the representation in favor of infectious genomes, while molecular cloning can introduce non-infectious (defective) genomes in the analysis [<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>,<xref rid="pgen.1008271.ref050" ref-type="bibr">50</xref>]. Whole genome quasispecies description is still technically challenging due to the artifactual introduction of mutations. Most current deep sequencing platforms yield sequences of short reads for a given amplicon (sequence under analysis); minority mutations in an amplicon cannot be reliably linked to mutations in a different amplicon of the same genome; at most, statistical inferences on linkage can be proposed. Despite these limitations, control experiments and improvements of bioinformatic procedures support that the majority of sequence heterogeneity analyzed in viral populations indeed reflects differences in the natural template populations. If mutation linkage can be solved on a routine basis, a new wave of molecular information relevant to epistatic interactions will enter the picture.</p><p>There are additional levels of indeterminacy in the sequential analysis of viral populations, in particular those replicating in vivo. Components of the mutant spectrum represented at a given time in the sample taken for sequencing may differ from those in the next time point, due either to sampling uncertainties or bona fide fluctuations of genome frequencies. It is not justified to accept a rough similarity because even a single mutation in a given sequence context may affect biological properties [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>]. In the words of John Holland and colleagues: &#x0201c;It is important to remember that every quasispecies genome swarm in an infected individual is unique and &#x0201c;new&#x0201d; in the sense that no identical population of genomes has ever existed before and none such will ever exist again&#x0201d; [<xref rid="pgen.1008271.ref055" ref-type="bibr">55</xref>]. On top of the fleeting nature of any mutant distribution, the standard methods available for quasispecies characterization provide genomic sequences of a minority of the population (estimated in 10<sup>&#x02212;8</sup> to 10<sup>&#x02212;13</sup> for molecular cloning-Sanger sequencing, and in 10<sup>&#x02212;6</sup> to 10<sup>&#x02212;11</sup> for deep sequencing; reviewed in [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]). We can only have an approximate representation of viral populations and their dynamics, as evidenced by many experimental studies [<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref012" ref-type="bibr">12</xref>,<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref034" ref-type="bibr">34</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>,<xref rid="pgen.1008271.ref051" ref-type="bibr">51</xref>,<xref rid="pgen.1008271.ref056" ref-type="bibr">56</xref>].</p></sec><sec id="sec006"><title>Consensus is not enough</title><p>The points summarized in previous sections fully justifies addressing analytical tools towards the mutant spectrum rather than ignoring it or considering its presence a side issue. Use of consensus sequences to describe the genome of a virus isolate, despite being warranted by the difficulties of conveying the information recapitulated in a mutant spectrum, blurs and enfeebles biological interpretations. Experimental results have demonstrated that minority genomes from a mutant spectrum (that cannot be identified by examining the consensus sequence) can include mutations that confer resistance to <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Antiviral_drug">antiviral inhibitors</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Neutralizing_antibody">neutralizing antibodies</ext-link> or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Cytotoxic_T_cells">cytotoxic T cells</ext-link>, or that can alter the capacity to induce <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Interferon">interferon</ext-link> (IFN) or to respond to IFN, virulence or particle stability, among other phenotypic traits [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>,<xref rid="pgen.1008271.ref037" ref-type="bibr">37</xref>,<xref rid="pgen.1008271.ref051" ref-type="bibr">51</xref>,<xref rid="pgen.1008271.ref056" ref-type="bibr">56</xref>&#x02013;<xref rid="pgen.1008271.ref060" ref-type="bibr">60</xref>]. Mutant spectra can also mediate cyclical adaptation to different cell types [<xref rid="pgen.1008271.ref061" ref-type="bibr">61</xref>]. A mutant spectrum defines a consensus but the consensus is an abstraction; it may not be represented in the population. Many events in viral pathogenesis and evolution are due to mutant spectrum modifications or interactions which cannot be properly interpreted solely on the basis of consensus sequences [<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>&#x02013;<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>,<xref rid="pgen.1008271.ref032" ref-type="bibr">32</xref>,<xref rid="pgen.1008271.ref034" ref-type="bibr">34</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1008271.ref044" ref-type="bibr">44</xref>,<xref rid="pgen.1008271.ref045" ref-type="bibr">45</xref>,<xref rid="pgen.1008271.ref048" ref-type="bibr">48</xref>,<xref rid="pgen.1008271.ref051" ref-type="bibr">51</xref>,<xref rid="pgen.1008271.ref055" ref-type="bibr">55</xref>].</p></sec></sec><sec id="sec007"><title>Collective responses: ensembles as units of selection</title><p>Mutant spectra are not mere aggregates of mutants acting independently. They are often engaged in collective responses of two major types: those that depend on the presence of sets of variants, and those that rely on intra-mutant spectrum interactions.</p><sec id="sec008"><title>Variants that drive responses to selective constraints</title><sec id="sec009"><title>Behavior of reconstructed quasispecies</title><p>In some cases of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/selective_sweep">sweeping selection</ext-link> (very strong selection for a trait), an individual (or a limited number of individuals) that encodes signatures prone to be selected, may approach dominance while becoming the founder of a mutant cloud (because formation of a cloud is inherent to replication). Conditions for dominance (in this case in response to selection) are that the genome senses the selective sweep and that its replication in the new selective environment is permitted. In other cases, a collection of mutants is selected. This was illustrated with a FMDV quasispecies that was reconstructed in the laboratory with multiple antigenic variants (each at low frequency) that belonged to two different categories, and shared resistance to the same <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Monoclonal_antibody">monoclonal antibody</ext-link> [<xref rid="pgen.1008271.ref062" ref-type="bibr">62</xref>]. One category included mutants with an amino acid substitution that affected <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Pattern_recognition_receptor">receptor recognition</ext-link> (since the antigenic determinant overlapped with the <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/integrin_receptor">integrin receptor</ext-link> recognition site); in the other category, the substitutions affected the antigenic determinant but not the receptor recognition site. Passages of the virus in absence of the monoclonal antibody resulted in dominance of antigenic variants that maintained the receptor recognition capacity, but the dominant variants were surrounded by a cloud of mutants of the other antigenic variant category. Conversely, passages in the presence of the antibody led to selection of variants with altered receptor recognition, surrounded by a cloud of antigenic variants that maintained receptor recognition. The results underlined the role of mutant clouds in selective events, and unveiled a new mechanism of antigenic flexibility [<xref rid="pgen.1008271.ref062" ref-type="bibr">62</xref>].</p></sec><sec id="sec010"><title>Quasispecies memory</title><p>Quasispecies memory is a type of molecular memory dependent on the recent history of the evolutionary lineage and the integrity of the mutant spectrum [<xref rid="pgen.1008271.ref057" ref-type="bibr">57</xref>,<xref rid="pgen.1008271.ref063" ref-type="bibr">63</xref>]. The search for memory was prompted by the complex adaptive system behavior of a viral quasispecies, suggested by the presence of core information (considered the one that defines viral identity) despite variation of constitutive elements (the mutant spectrum). A well-known example is <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Immunological_memory">memory in the immune system</ext-link> that mobilizes and expands minority components in response to stimuli previously faced by the system [<xref rid="pgen.1008271.ref064" ref-type="bibr">64</xref>]. In the experiments designed to identify memory in viral quasispecies, members of the mutant spectrum increased in frequency as a consequence of their replication during a selection event that drove them towards dominance. When the selective constraint was withdrawn, memory genomes remained at levels that were 10- to 100-fold higher than the basal levels attributable solely to their generation by mutation, as documented with independent FMDV genetic markers, and with HIV-1 <italic>in vivo</italic> [<xref rid="pgen.1008271.ref057" ref-type="bibr">57</xref>,<xref rid="pgen.1008271.ref063" ref-type="bibr">63</xref>,<xref rid="pgen.1008271.ref065" ref-type="bibr">65</xref>,<xref rid="pgen.1008271.ref066" ref-type="bibr">66</xref>]. Thus, memory is a history-dependent, collective property of the quasispecies that confers a selective advantage to respond to environmental changes previously experienced by the same evolutionary lineage. It can be manifested only if the mutant spectrum maintains its completeness, since memory is lost when the population undergoes a <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/population_bottleneck">bottleneck</ext-link> event that excludes minorities. A relevant example of the consequences of memory occurs in antiviral pharmacology with the administration for a second time of the same or a related antiviral agent (capable of evoking shared resistance mutations) used in a previous treatment. The second intervention may face inhibitor-resistant memory genomes from the earlier treatment, thus contributing to virus escape [<xref rid="pgen.1008271.ref057" ref-type="bibr">57</xref>]. This is an aspect that has not received adequate attention in the planning of antiviral interventions for patients who fail a first treatment and have to be subjected to a second treatment.</p></sec></sec><sec id="sec011"><title>Intra-mutant spectrum interactions for interference, complementation or cooperation</title><p><bold>Individual genomes</bold> surrounded by a cloud of related mutants can be either suppressed to be kept at low frequency, or helped to be maintained in the population. The two alternative fates are dependent on several factors, one being the surrounding mutant spectrum in those steps of the infectious cycle in which an effective competition among variants is established, for example within replication complexes. This important concept was first derived theoretically [<xref rid="pgen.1008271.ref003" ref-type="bibr">3</xref>,<xref rid="pgen.1008271.ref067" ref-type="bibr">67</xref>], and then approached experimentally with several viruses. In an early study, Juan Carlos de la Torre and John Holland described suppression of high fitness VSV by mutant spectra of inferior fitness [<xref rid="pgen.1008271.ref068" ref-type="bibr">68</xref>]. Suppressive effects have since been documented with standard and mutagenized viral populations. Some examples are:</p><list list-type="bullet"><list-item><p>Suppression of high fitness antigenic variants of FMDV by low fitness antibody-escape mutants [<xref rid="pgen.1008271.ref069" ref-type="bibr">69</xref>].</p></list-item><list-item><p>&#x0200f;Suppression of virulent <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Poliovirus">poliovirus</ext-link> (PV) by attenuated virus in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Poliovirus_vaccine">poliovirus vaccines</ext-link> [<xref rid="pgen.1008271.ref058" ref-type="bibr">58</xref>].</p></list-item><list-item><p>Suppression of pathogenic <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Lymphocytic_choriomengitis_virus">lymphocytic choriomengitis virus</ext-link> (LCMV) (that cause growth hormone deficiency in mice) by non-pathogenic LCMV variants [<xref rid="pgen.1008271.ref070" ref-type="bibr">70</xref>].</p></list-item><list-item><p>Suppression of FMDV by a mutagenized FMDV population [<xref rid="pgen.1008271.ref071" ref-type="bibr">71</xref>].</p></list-item><list-item><p>Suppression of FMDV by capsid and polymerase FMDV mutants [<xref rid="pgen.1008271.ref072" ref-type="bibr">72</xref>].</p></list-item><list-item><p>Suppression of drug-resistant viral mutants during antiviral therapy [<xref rid="pgen.1008271.ref073" ref-type="bibr">73</xref>,<xref rid="pgen.1008271.ref074" ref-type="bibr">74</xref>].</p></list-item></list><p>Opposite to suppression is maintenance of a mutant either by a favorable position in a fitness landscape or by interactions of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Complementation_(genetics">complementation</ext-link> or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Cooperation">cooperation</ext-link> with members of the mutant spectrum. The position in a fitness landscape influences vulnerability to mutations, as popularized with the terms &#x0201c;advantage of the flattest&#x0201d; or &#x0201c;survival of the flattest&#x0201d;, indicating that a variant located at the top of a sharp fitness peak has higher probability to decrease fitness as a result of new mutations than the same variant located at a <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Fitness_plateau">fitness plateau</ext-link> [<xref rid="pgen.1008271.ref075" ref-type="bibr">75</xref>&#x02013;<xref rid="pgen.1008271.ref077" ref-type="bibr">77</xref>]. Survival of the flattest has been also proposed as an ingredient in some models of the error threshold [<xref rid="pgen.1008271.ref078" ref-type="bibr">78</xref>].</p><p>Collective behavior of viruses was documented with mutant RNA viruses resistant to nucleotide analogues. The study of this class of mutants has been instrumental for the understanding of the molecular basis of template copying fidelity, and the consequences of fidelity alterations in the adaptive capacity and pathogenic potential of RNA viruses [<xref rid="pgen.1008271.ref079" ref-type="bibr">79</xref>&#x02013;<xref rid="pgen.1008271.ref081" ref-type="bibr">81</xref>]. In the first mutant studied, amino acid substitution G46S in the PV polymerase resulted in about four-fold increase in template-copying fidelity. This modification reduced PV adaptability and infective potential <italic>in vivo</italic> [<xref rid="pgen.1008271.ref079" ref-type="bibr">79</xref>,<xref rid="pgen.1008271.ref080" ref-type="bibr">80</xref>]. The mutant in isolation did not replicate efficiently in the brain of susceptible mice, but it did when its mutant spectrum was broadened by <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/5-fluorouracil">5-fluorouracil</ext-link> mutagenesis or when it was co-inoculated with wild type PV [<xref rid="pgen.1008271.ref080" ref-type="bibr">80</xref>].</p><p>Complementation (often occurring when a functional protein encoded by a set of genomes is used by another set of genomes whose encoded protein is not functional) may underlie some collective responses of quasispecies such as fitness of individuals isolated from a population being inferior to fitness of the population [<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref007" ref-type="bibr">7</xref>]. Complementation was described between two truncated FMDV genomic forms [<xref rid="pgen.1008271.ref056" ref-type="bibr">56</xref>,<xref rid="pgen.1008271.ref082" ref-type="bibr">82</xref>]. The genomes with internal deletions became detectable upon high multiplicity passage of a clonal population of standard FMDV, a virus with a monopartite single stranded RNA genome. Infectivity was generated by complementation of the two truncated forms, in absence of standard, full length FMDV genomes. For complementation to be effective, prior exploration of sequence space through point mutations was a requirement [<xref rid="pgen.1008271.ref083" ref-type="bibr">83</xref>]. The system underwent a remarkable evolutionary transition akin to genome segmentation. Drastic genetic lesions in viral genomes are difficult to observe unless a mechanism such as complementation comes into the rescue of the deviant genomes. Additional examples of complementation among RNA viruses have been reported ([<xref rid="pgen.1008271.ref084" ref-type="bibr">84</xref>&#x02013;<xref rid="pgen.1008271.ref086" ref-type="bibr">86</xref>]; for review see [<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>]). Complementation is a means to maintain defective genomes at detectable frequencies in viral populations.</p><p>A distinction has been made between complementation and cooperation, in which two different genomes give rise to a new phenotype through the interaction between two variant proteins [<xref rid="pgen.1008271.ref087" ref-type="bibr">87</xref>]. An example of cooperation was characterized during studies with measles virus on membrane fusion which is essential for virus entry into cells. For this virus fusion is mediated by two proteins termed H and F. A truncated H was deficient in cell fusion but the activity was regained when the truncated H was accompanied by two forms of F but not one of the forms individually [<xref rid="pgen.1008271.ref087" ref-type="bibr">87</xref>].</p><p>Therefore, complementation, cooperation, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/clonal_interference">interference</ext-link> and suppression can emerge from interactions among components of mutant spectra that have their origin in random mutations. Selection acts on whatever sets of mutants can provide a useful trait, to turn random occurrences into biological meaning.</p></sec></sec><sec id="sec012"><title>Bottlenecks: Weakening, liberation, or challenge?</title><p>A means to interrupt the participation of individual genomes in interactions with their mutant spectrum is for the quasispecies swarm to undergo drastic reductions in population size that isolate one or few individual genomes from their surroundings. Such reductions are termed bottlenecks (<xref ref-type="fig" rid="pgen.1008271.g004">Fig 4</xref>), and they have an important participation in shaping evolutionary lineages for all kinds of organisms, and also for viruses. Bottleneck events are also depicted in <xref ref-type="fig" rid="pgen.1008271.g003">Fig 3</xref> (plaque-to-plaque transfers in box at the left). They occur frequently not only upon host-to host transmission but also inside infected hosts [<xref rid="pgen.1008271.ref088" ref-type="bibr">88</xref>&#x02013;<xref rid="pgen.1008271.ref090" ref-type="bibr">90</xref>], and they can perturb positive and negative selection events in processes that are difficult to identify and characterize.</p><fig id="pgen.1008271.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1008271.g004</object-id><label>Fig 4</label><caption><title>Illustration of bottleneck of different severity, defined by the different arrows acting on the entire population.</title><p>Symbols represent mutation types.</p></caption><graphic xlink:href="pgen.1008271.g004"/></fig><p>Drastic bottleneck events have been reproduced with laboratory populations of viruses in the form of plaque-to-plaque transfers [<xref rid="pgen.1008271.ref091" ref-type="bibr">91</xref>,<xref rid="pgen.1008271.ref092" ref-type="bibr">92</xref>] (depicted in <xref ref-type="fig" rid="pgen.1008271.g003">Fig 3</xref>). This design served to verify experimentally the operation of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/M%C3%BCller%E2%80%99s_ratchet">M&#x000fc;ller&#x02019;s ratchet</ext-link>, or fitness decrease by the irreversible incorporation of mutations in asexual organisms in absence of compensatory mechanisms [<xref rid="pgen.1008271.ref093" ref-type="bibr">93</xref>]. The serial bottleneck transfers unveiled the presence of rare mutations, not seen in standard laboratory or natural viral populations. In absence of forced bottleneck events, such rare mutations would be lost by negative selection because of the fitness cost they inflict [<xref rid="pgen.1008271.ref094" ref-type="bibr">94</xref>]. The investigation of how FMDV clones debilitated by M&#x000fc;ller&#x02019;s ratchet regained replicative fitness revealed several alternative molecular pathways for fitness recovery [<xref rid="pgen.1008271.ref095" ref-type="bibr">95</xref>]. The implications of this observation went largely unnoticed until recent results with <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Hepatitis_C_virus">hepatitis C virus</ext-link> (HCV) have also suggested the accessibility of multiple pathways for fitness gain [<xref rid="pgen.1008271.ref051" ref-type="bibr">51</xref>,<xref rid="pgen.1008271.ref054" ref-type="bibr">54</xref>]. Also, extensive passage of a biological clone of FMDV in <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Baby_hamster_kidney_cell">BHK-21 cells</ext-link> conferred the capacity to infect several human cell lines in addition to the expected fitness increase for multiplication in BHK-21 cells [<xref rid="pgen.1008271.ref096" ref-type="bibr">96</xref>]. Thus, several lines of evidence suggest that fitness gain in a specific environment may paradoxically broaden the phenotypic potential of a virus. It will be interesting to investigate whether focused adaptation of other viruses to a specific environment may also entail a broadening of diversity, with many phenotypic variants attaining similar fitness levels. If generalized, this broadening of phenotypic space would provide a new interpretation of the molecular basis of adaptation, and explain why adaptation to alternative environments may not lead to <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_attenuation">attenuation</ext-link>.</p><p>Deprivation of an individual virus from possible suppression, complementation or cooperation, may represent a liberation to initiate a new evolutionary process, or a condemnation to extinction. If liberated from suppression, the isolated genome must replicate and be able to reconstruct a mutant cloud to regain adaptive capability. This has led to the suggestion that high mutation rates evolved to allow such mutant spectrum recovery following bottlenecks. Other models attribute high mutation rates to adaptive optimization independent of bottlenecks, or to a mechanistic consequence of rapid replication (reviewed in [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]). Whatever their ultimate origins, high mutation rates serve the purpose of adaptation in multiple circumstances, not only following bottlenecks. A founder virus can introduce a different phenotype for the ensuing evolution. Evolution of viruses in nature and as disease agents can be viewed as succession of mutant spectrum alterations, subjected to expansions and reductions of population size in a continuous interplay of positive and negative selection and random drift. While short-term (for example, intra-host) evolution is observable and measurable, viruses may appear to be relatively static in the long term for decades (as seen with antigenic variants of FMDV [<xref rid="pgen.1008271.ref097" ref-type="bibr">97</xref>]) or longer. Intra-host evolution is generally more rapid than inter-host evolution, as documented with viruses [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>] and other biological systems [<xref rid="pgen.1008271.ref098" ref-type="bibr">98</xref>]. Apparent invariance may be the result of selection for long-term survival of populations that have previously frenziedly tested evolutionary outcomes in short-term processes [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>].</p></sec><sec id="sec013"><title>Quasispecies and viral disease</title><p>Soon after quasispecies was evidenced for viruses, some medical implications were made explicit [<xref rid="pgen.1008271.ref012" ref-type="bibr">12</xref>,<xref rid="pgen.1008271.ref099" ref-type="bibr">99</xref>]. Several specific or general points (reviewed in [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref034" ref-type="bibr">34</xref>,<xref rid="pgen.1008271.ref059" ref-type="bibr">59</xref>], and in several chapters of [<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>]) can be succinctly exposed as follows:</p><list list-type="bullet"><list-item><p>High mutation rates and population heterogeneity endow viruses with the potential to escape immune pressures (including those due to <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Vaccination">vaccination</ext-link>) and antiviral inhibitors used in therapy. It is an open question if vaccination can promote long-term evolution of antigenic determinants.</p></list-item><list-item><p>Attenuated RNA virus vaccines can revert to virulent forms. RNA viruses released in nature for <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Pest_control">pest control</ext-link> purposes can mutate to new phenotypes.</p></list-item><list-item><p>Virus attenuation and virulence is dependent on viral genetic traits. Variant forms of a given virus may display increased virulence or atypical disease.</p></list-item><list-item><p>Components of a mutant spectrum can exhibit a different <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Cell_tropism">cell tropism</ext-link> or <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Host_range">host range</ext-link> than most genomes in the same population, with implications for the emergence and re-emergence of viral disease.</p></list-item><list-item><p>Viral pathogenesis is influenced by <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Microevolution">microevolutionary</ext-link> processes in which some viral subpopulations are replaced by others to persist or to invade new cell types, tissues or organs.</p></list-item><list-item><p>The larger the actively replicating (effective) population size and the replication rate, the most effective is exploration of sequence space for phenotypic expansions that favor survival and persistence.</p></list-item><list-item><p>There is a connection between four parameters that caracterize viruses during infection processes: replication rate (the rate at which viral RNA or DNA is synthesized intracellularly for viral progeny production), viral load (the total amount of virus quantified in an infected host or host compartment), genetic heterogeneity, and replicative fitness (the yield of infectious particles that can contribute to the next generation). They can influence disease progression, and any of them can be targetted for disease control.</p></list-item></list><p>In all interactions conductive to disease, the host cells individually and as groups in tissues and organs play decisive roles. The consequences of a viral infection are always host-dependent. However, the virus itself poses a major challenge that a deeper understanding of quasispecies dynamics is helping to confront.</p></sec><sec id="sec014"><title>Antiviral strategies in response to the quasispecies challenge</title><p>There is an increasing perception that Darwinian principles should <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Applications_of_evolution">assist in the planning</ext-link> of antiviral designs [<xref rid="pgen.1008271.ref100" ref-type="bibr">100</xref>]. The aim of vaccination is to evoke a protective response that either prevents virus replication or disease. The aim of an antiviral pharmacological intervention is to inhibit virus replication to provide the immune system with an opportunity to clear the virus. Expressed simply, the direct danger for vaccination and treatment is that virus can escape through selection of mutants resistant to vaccine-triggered defense components or to the externally administered inhibitors. This has led to several proposals to confront viral disease, that can be summarized as follows (reviewed in [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]):</p><sec id="sec015"><title>Vaccines should expose multiple B cell and T cell epitopes to the immune system</title><p>Vaccines should include repertoires of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/B_cell">B cell</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/T_cell">T cell</ext-link> epitopes to evoke an ample <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Immune_response">immune response</ext-link>. The broad response should minimize selection of escape mutants that may be present as minority components in mutant spectra, as repeatedly documented experimentally [<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>,<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1008271.ref057" ref-type="bibr">57</xref>]. With the current types of available vaccines, those that best comply with the multiple <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Epitope">epitope</ext-link> requirement are, in the order of expected efficacy to confer protection against highly variable viruses: <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Attenuated_vaccine">attenuated</ext-link> &#x0003e; <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Inactivated_vaccine%5C%5C">inactivated whole virus</ext-link> &#x0003e; several expressed proteins &#x0003e; <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Toxoid">one expressed protein</ext-link> &#x0003e; <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Vaccine#Experimental">multiple synthetic peptide antigens</ext-link> &#x0003e; single peptide antigen. The scarcity of effective synthetic vaccines for RNA viral pathogens despite huge scientific and economic efforts is a reflection of the underlying problems.</p></sec><sec id="sec016"><title>Antiviral agents should be used in combination</title><p>Antiviral <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Monotherapy">monotherapy</ext-link> (use of a single antiviral agent) is to be avoided. The following recommendations have been made and in some cases successfully implemented:</p><list list-type="bullet"><list-item><p>Inhibitors used in combination should target different viral gene products.</p></list-item><list-item><p>Splitting a treatment into two steps: first an induction regimen, and a second maintenance regimen. Drugs administered in the two steps should be different.</p></list-item><list-item><p>Targetting of cellular functions needed for the virus life cycle.</p></list-item><list-item><p>Use of innate immune response-stimulating drugs (for example, inhibitors of enzymes involved in pyrimidine biosynthesis).</p></list-item><list-item><p>Combined use of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Immunotherapy">immunotherapy</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Chemotherapy">chemotherapy</ext-link>.</p></list-item><list-item><p>Lethal mutagenesis or virus extinction by excess of mutations introduced during viral replication.</p></list-item></list><p>These strategies (whose supportive theoretical and experimental evidence has been reviewed in [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>,<xref rid="pgen.1008271.ref060" ref-type="bibr">60</xref>]) have as their main objective to avoid selection of treatment-escape mutants by multiple selective constraints that cannot be surmounted by the virus. Control is effective either because exploration of sequence space cannot reach the required multiple mutations (even when recombination is available) or because the multiple mutations inflict a severe fitness cost [<xref rid="pgen.1008271.ref101" ref-type="bibr">101</xref>]. Vaccines exposing multiple epitopes and combination therapies follow the same strategy whose aim is to limit possible escape routes to viral quasispecies in the face of the suppressive constraint.</p></sec><sec id="sec017"><title>Lethal mutagenesis</title><p><ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Lethal_mutagenesis">Lethal mutagenesis</ext-link> is the process of virus extinction at the error rate at which a virus can no longer maintain its genetic information [<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>,<xref rid="pgen.1008271.ref054" ref-type="bibr">54</xref>,<xref rid="pgen.1008271.ref078" ref-type="bibr">78</xref>,<xref rid="pgen.1008271.ref102" ref-type="bibr">102</xref>,<xref rid="pgen.1008271.ref103" ref-type="bibr">103</xref>]. Application of lethal mutagenesis as an antiviral strategy deserves attention in the context of the present article because its origins lie in quasispecies theory, in the form of the error threshold relationship (<xref ref-type="fig" rid="pgen.1008271.g001">Fig 1</xref>). Both the error threshold and lethal mutagenesis are highly fitness landscape-dependent, but both can occur in complex fitness landscapes as those pertinent to viral populations [<xref rid="pgen.1008271.ref005" ref-type="bibr">5</xref>]. The term lethal mutagenesis was coined by Lawerence Loeb and colleagues [<xref rid="pgen.1008271.ref102" ref-type="bibr">102</xref>], and it is now widely used to describe the antiviral activity of base and nucleoside analogues that increase the viral mutation rate. Although several models have been proposed to account for virus extinction by excess mutations [<xref rid="pgen.1008271.ref078" ref-type="bibr">78</xref>], an extension of the violation of the error threshold stands as a likely mechanism ([<xref rid="pgen.1008271.ref104" ref-type="bibr">104</xref>]; recent review in [<xref rid="pgen.1008271.ref103" ref-type="bibr">103</xref>]). Interestingly, some antiviral agents licensed for human use, initially thought to act only as inhibitors of viral replication, may actually exert their antviral activity against some RNA viruses at least partially by lethal mutagenesis. This is the case of <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Favipiravir">favipiravir</ext-link> (T-705; 6-fluoro-3-hydroxy-2-pirazinecarboxamide) and <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Ribavirin">ribavirin</ext-link> (1-&#x003b2;-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide) that are currently being intensively investigated as lethal mutagens [<xref rid="pgen.1008271.ref103" ref-type="bibr">103</xref>].</p><p>Defense mechanisms based on genome modification of invading genetic parasites such as editing cellular activities that are recruited as part of the innate immune response (<ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/ADAR">ADAR</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/APOBEC">APOBEC</ext-link>, <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Ribosome-inactivating_protein">RIP</ext-link>, etc; reviewed in [<xref rid="pgen.1008271.ref105" ref-type="bibr">105</xref>]) represent a natural counterpart of the principle utilized by lethal mutagenesis. Applicability to pathogenic cellular elements is a real possibility, and lethal mutagenesis to control tumor cells is an active field of investigation [<xref rid="pgen.1008271.ref106" ref-type="bibr">106</xref>,<xref rid="pgen.1008271.ref107" ref-type="bibr">107</xref>]. Thus, the recognition of quasispecies dynamics has suggested some fundamental guidelines for disease prevention and control that are gradually permeating clinical practice. This is in line with the recognized need to apply Darwinian principles to the control of infectious disease.</p></sec></sec><sec id="sec018"><title>Summary and prospects</title><p>The main concepts covered in the present article and their domains of applicability are summarized in <xref rid="pgen.1008271.t001" ref-type="table">Table 1</xref>. The adequacy of quasispecies theory (versus other formulations of evolutionary dynamics [<xref rid="pgen.1008271.ref108" ref-type="bibr">108</xref>]) as a framework for the error-prone replication of viruses and its consequences stems from its including mutation as an integral part of the replication process [<xref rid="pgen.1008271.ref013" ref-type="bibr">13</xref>]. Quasispecies dynamics poses a great challenge for the molecular interpretation of short-term evolutionary events that bear on virus-host interactions and disease processes. A rewarding aspect of progress in having captured the meaning of the challenge (at least partially) is that we can exclude some of the prevention and control strategies that once were considered an option. A significant example is the historical rejection of combination therapies as contrary to the established canons of pharmacology, while now monotherapy is considered a risky practice (for discussion of this point, see [<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]). We understand now that focused antiviral barriers that involve a single constraint (one inhibitor, one monoclonal antibody, one peptide antigen as vaccine) have a large probability of failing. Likewise, attempts to produce &#x0201c;universal&#x0201d; drugs, vaccines or diagnostic tools are unlikely to succeed given the intra-population diversity (present and potential) of the pathogenic agents to be controlled. A viral genome region which is conserved among types, subtypes, isolates may be so only regarding a consensus sequence but not the underlying mutant spectrum. Methods are now available to identify low level mutations that may predict escape from selective constraints. On a related note, it remains extremely unlikely to predict the emergence and re-emergence of viral diseases for a number of interconnected reasons, not the least important being pathogen adaptability [<xref rid="pgen.1008271.ref109" ref-type="bibr">109</xref>]. The outlined limitations to predict the occurrence of viral diseases and to control them are based on our current understanding of viral complexity and dynamic change of such complexity. Obviously, we may be wrong, and in science we are open to the unexpected.</p><table-wrap id="pgen.1008271.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pgen.1008271.t001</object-id><label>Table 1</label><caption><title>Summary of main concepts related to quasispecies and their implications <xref ref-type="table-fn" rid="t001fn001">a</xref>.</title></caption><alternatives><graphic id="pgen.1008271.t001g" xlink:href="pgen.1008271.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Concept</th><th align="left" rowspan="1" colspan="1">Implications for virology</th><th align="left" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Error-prone replication and mutant spectra</bold></td><td align="left" rowspan="1" colspan="1">Limited template-copying fidelity leads to formation of dynamic mutant distributions. They mediate virus adaptability.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref001" ref-type="bibr">1</xref>,<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref009" ref-type="bibr">9</xref>,<xref rid="pgen.1008271.ref013" ref-type="bibr">13</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Phenotypic reservoir</bold></td><td align="left" rowspan="1" colspan="1">Mutant spectra are a phenotypic reservoir for selection to act upon</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref017" ref-type="bibr">17</xref>,<xref rid="pgen.1008271.ref020" ref-type="bibr">20</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Adaptive parameters</bold></td><td align="left" rowspan="1" colspan="1">Viral quasispecies adaptability relies on six parameters: genome size; population size; replication rate; mutation rate; fecundity; and number of mutations required for a phenotypic change</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref035" ref-type="bibr">35</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Intra-mutant spectrum interactions</bold></td><td align="left" rowspan="1" colspan="1">Mutant spectra are not mere mutant aggregates. Emergent behavior can result from positive interactions of cooperation or complementation or negative interactions of interference among components cf the mutant spectrum</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref007" ref-type="bibr">7</xref>,<xref rid="pgen.1008271.ref068" ref-type="bibr">68</xref>&#x02013;<xref rid="pgen.1008271.ref070" ref-type="bibr">70</xref>,<xref rid="pgen.1008271.ref082" ref-type="bibr">82</xref>,<xref rid="pgen.1008271.ref085" ref-type="bibr">85</xref>&#x02013;<xref rid="pgen.1008271.ref087" ref-type="bibr">87</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Quasispecies memory</bold></td><td align="left" rowspan="1" colspan="1">A record of past genome dominances that prepares a viral population to respond to a selective constraint previously experienced by the same lineage. Bottlenecks erase quasispecies memory.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref057" ref-type="bibr">57</xref>,<xref rid="pgen.1008271.ref063" ref-type="bibr">63</xref>,<xref rid="pgen.1008271.ref065" ref-type="bibr">65</xref>,<xref rid="pgen.1008271.ref066" ref-type="bibr">66</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Sequence space</bold></td><td align="left" rowspan="1" colspan="1">The total number of genomic sequences available to a virus. Adaptation is a movement towards a favorable region of sequence space. De-adaptation (i.e. lethal mutagenesis) is a movement towards unfavorable regions of sequence space.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref002" ref-type="bibr">2</xref>,<xref rid="pgen.1008271.ref014" ref-type="bibr">14</xref>,<xref rid="pgen.1008271.ref037" ref-type="bibr">37</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Population bottleneck</bold></td><td align="left" rowspan="1" colspan="1">A drastic reduction in population size. It promotes random drift in evolutionary outcomes. The diversifying effect of bottlenecks is accentuated by the cloud nature of viral populations.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref088" ref-type="bibr">88</xref>,<xref rid="pgen.1008271.ref090" ref-type="bibr">90</xref>,<xref rid="pgen.1008271.ref091" ref-type="bibr">91</xref>,<xref rid="pgen.1008271.ref094" ref-type="bibr">94</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Biological constraints</bold></td><td align="left" rowspan="1" colspan="1">High mutation rates expand sequence space occupation. Biological constraints impose negative selection on many newly generated mutants. Constraints contribute to maintenance of virus identity.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref006" ref-type="bibr">6</xref>,<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref033" ref-type="bibr">33</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Connections with viral pathogenesis</bold></td><td align="left" rowspan="1" colspan="1">Progress of an infection is often associated with virus adaptation to host environments. Variants of the same virus can differ in disease potential (virulence).</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref016" ref-type="bibr">16</xref>,<xref rid="pgen.1008271.ref018" ref-type="bibr">18</xref>,<xref rid="pgen.1008271.ref049" ref-type="bibr">49</xref>]</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Quasispecies and long-term evolution</bold></td><td align="left" rowspan="1" colspan="1">Short-term evolutionary rate based on reorganization of mutant spectra is faster than long-term evolutionary rate. Conceptual links between quasispecies and phylodynamics at the epidemiological level are needed.</td><td align="left" rowspan="1" colspan="1">[<xref rid="pgen.1008271.ref111" ref-type="bibr">111</xref>]</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>aConcepts are listed in the order relevant to the topics covered in the text, and serve to underline key points and some supportive studies. The concepts are expanded in the text, with additional references.</p></fn></table-wrap-foot></table-wrap><p>Quasispecies poses also a challenge for the annotation of the events we witness. Reality is far more complex than the means we have developed to describe viral populations in continuous change. How could the problem we approached? Procedures to organize and relate sequences for phylodynamic purposes need updating to exploit increased computing power to handle mutant spectra rather than one or few (consensus or other) sequences from each biological sample. The expanding number of sequences expected to become available including complete genomes (that will allow mutation linkage to enter the picture) if handled properly, may inform of the molecular basis of new phenotypes. The penetration into mutant spectra has also modified the concept of rare mutation since what in terms of consensus could be catalogued as rare may in fact be frequently occurring but rarely observed. A mutation which has low frequency at one time point or in a given environment may rise to high frequency at another time point or in a different environment. Rare mutations that populate mutant swarms may belong to defective genomes exerting relevant host interactions [<xref rid="pgen.1008271.ref110" ref-type="bibr">110</xref>]. On a more general note, recognition of viral quasispecies was premonitory of the impressive diversity in the biological world that the metagenomic approaches are currently unveiling, including cellular heterogeneities whose biological implications remain largely unexplored.</p></sec><sec sec-type="supplementary-material" id="sec019"><title>Supporting information</title><supplementary-material content-type="local-data" id="pgen.1008271.s001"><label>S1 Text</label><caption><title>Version history of the text file.</title><p>(XML)</p></caption><media xlink:href="pgen.1008271.s001.xml"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pgen.1008271.s002"><label>S2 Text</label><caption><title>Peer reviews and response to reviews.</title><p>(XML)</p></caption><media xlink:href="pgen.1008271.s002.xml"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank colleagues and students who have participated in research on viral quasispecies and its conceptual origins. We dedicate this article to the memory of Manfred Eigen (1927&#x02013;2019).</p></ack><fn-group><fn fn-type="other" id="fn001"><p><bold>Wikipedia Version</bold>: <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Viral_quasispecies">https://en.wikipedia.org/wiki/Viral_quasispecies</ext-link></p></fn></fn-group><ref-list><title>References</title><ref id="pgen.1008271.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>Eigen</surname><given-names>M</given-names></name> (<year>1971</year>) <article-title>Self-organization of matter and the evolution of biological macromolecules</article-title>. <source>Naturwissenschaften</source>
<volume>58</volume>: <fpage>465</fpage>&#x02013;<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1007/bf00623322</pub-id>
<?supplied-pmid 4942363?><pub-id pub-id-type="pmid">4942363</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref002"><label>2</label><mixed-citation publication-type="book"><name><surname>Eigen</surname><given-names>M</given-names></name>, <name><surname>Schuster</surname><given-names>P</given-names></name> (<year>1979</year>) <chapter-title>The hypercycle. A principle of natural self-organization</chapter-title>
<publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer</publisher-name>.</mixed-citation></ref><ref id="pgen.1008271.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Swetina</surname><given-names>J</given-names></name>, <name><surname>Schuster</surname><given-names>P</given-names></name> (<year>1982</year>) <article-title>Self-replication with errors. A model for polynucleotide replication</article-title>. <source>Biophys Chem</source>
<volume>16</volume>: <fpage>329</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/0301-4622(82)87037-3</pub-id>
<?supplied-pmid 7159681?><pub-id pub-id-type="pmid">7159681</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Fornes</surname><given-names>J</given-names></name>, <name><surname>Tomas Lazaro</surname><given-names>J</given-names></name>, <name><surname>Alarcon</surname><given-names>T</given-names></name>, <name><surname>Elena</surname><given-names>SF</given-names></name>, <name><surname>Sardanyes</surname><given-names>J</given-names></name> (<year>2019</year>) <article-title>Viral replication modes in single-peak fitness landscapes: A dynamical systems analysis</article-title>. <source>J Theor Biol</source>
<volume>460</volume>: <fpage>170</fpage>&#x02013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.jtbi.2018.10.007</pub-id>
<?supplied-pmid 30300648?><pub-id pub-id-type="pmid">30300648</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Schuster</surname><given-names>P</given-names></name> (<year>2016</year>) <article-title>Quasispecies on fitness landscapes</article-title>. In: <name><surname>Domingo</surname><given-names>E.</given-names></name> and <name><surname>Schuster</surname><given-names>P.</given-names></name>, eds. <article-title>Quasispecies: From Theory to Experimental Systems</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>61</fpage>&#x02013;<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_469</pub-id>
<?supplied-pmid 26597856?></mixed-citation></ref><ref id="pgen.1008271.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Sabo</surname><given-names>D</given-names></name>, <name><surname>Taniguchi</surname><given-names>T</given-names></name>, <name><surname>Weissmann</surname><given-names>C</given-names></name> (<year>1978</year>) <article-title>Nucleotide sequence heterogeneity of an RNA phage population</article-title>. <source>Cell</source>
<volume>13</volume>: <fpage>735</fpage>&#x02013;<lpage>744</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(78)90223-4</pub-id>
<?supplied-pmid 657273?><pub-id pub-id-type="pmid">657273</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Duarte</surname><given-names>EA</given-names></name>, <name><surname>Novella</surname><given-names>IS</given-names></name>, <name><surname>Ledesma</surname><given-names>S</given-names></name>, <name><surname>Clarke</surname><given-names>DK</given-names></name>, <name><surname>Moya</surname><given-names>A</given-names></name>, <name><surname>Elena</surname><given-names>SF</given-names></name>, <etal>et al</etal> (<year>1994</year>) <article-title>Subclonal components of consensus fitness in an RNA virus clone</article-title>. <source>J Virol</source>
<volume>68</volume>: <fpage>4295</fpage>&#x02013;<lpage>4301</lpage>. <?supplied-pmid 8207804?><pub-id pub-id-type="pmid">8207804</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref008"><label>8</label><mixed-citation publication-type="book"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Brun</surname><given-names>A</given-names></name>, <name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>JI</given-names></name>, <name><surname>Cristina</surname><given-names>J</given-names></name>, <name><surname>Briones</surname><given-names>C</given-names></name>, <name><surname>Escarm&#x000ed;s</surname><given-names>C</given-names></name> (<year>2006</year>) <chapter-title>Genomics of Viruses</chapter-title> In: <name><surname>Hacker</surname><given-names>J</given-names></name>, <name><surname>Dobrindt</surname><given-names>U</given-names></name>, editors. <source>Pathogenomics: Genome Analysis of Pathogenic Microbes</source>. <publisher-loc>Weinheim</publisher-loc>: <publisher-name>Wiley-VCH Verlag GmbH &#x00026; Co. KGaA</publisher-name> pp. <fpage>369</fpage>&#x02013;<lpage>388</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Batschelet</surname><given-names>E</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Weissmann</surname><given-names>C</given-names></name> (<year>1976</year>) <article-title>The proportion of revertant and mutant phage in a growing population, as a function of mutation and growth rate</article-title>. <source>Gene</source>
<volume>1</volume>: <fpage>27</fpage>&#x02013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(76)90004-4</pub-id>
<?supplied-pmid 1052321?><pub-id pub-id-type="pmid">1052321</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Drake</surname><given-names>JW</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name> (<year>1999</year>) <article-title>Mutation rates among RNA viruses</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>96</volume>: <fpage>13910</fpage>&#x02013;<lpage>13913</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.24.13910</pub-id>
<?supplied-pmid 10570172?><pub-id pub-id-type="pmid">10570172</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Bradwell</surname><given-names>K</given-names></name>, <name><surname>Combe</surname><given-names>M</given-names></name>, <name><surname>Domingo-Calap</surname><given-names>P</given-names></name>, <name><surname>Sanjuan</surname><given-names>R</given-names></name> (<year>2013</year>) <article-title>Correlation between mutation rate and genome size in riboviruses: mutation rate of bacteriophage Qbeta</article-title>. <source>Genetics</source>
<volume>195</volume>: <fpage>243</fpage>&#x02013;<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.113.154963</pub-id>
<?supplied-pmid 23852383?><pub-id pub-id-type="pmid">23852383</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Holland</surname><given-names>JJ</given-names></name>, <name><surname>Spindler</surname><given-names>K</given-names></name>, <name><surname>Horodyski</surname><given-names>F</given-names></name>, <name><surname>Grabau</surname><given-names>E</given-names></name>, <name><surname>Nichol</surname><given-names>S</given-names></name>, <name><surname>VandePol</surname><given-names>S</given-names></name> (<year>1982</year>) <article-title>Rapid evolution of RNA genomes</article-title>. <source>Science</source>
<volume>215</volume>: <fpage>1577</fpage>&#x02013;<lpage>1585</lpage>. <pub-id pub-id-type="doi">10.1126/science.7041255</pub-id>
<?supplied-pmid 7041255?><pub-id pub-id-type="pmid">7041255</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Mart&#x000ed;nez-Salas</surname><given-names>E</given-names></name>, <name><surname>Sobrino</surname><given-names>F</given-names></name>, <name><surname>de la Torre</surname><given-names>JC</given-names></name>, <name><surname>Portela</surname><given-names>A</given-names></name>, <name><surname>Ort&#x000ed;n</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1985</year>) <article-title>The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance&#x02014;a review</article-title>. <source>Gene</source>
<volume>40</volume>: <fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name>, <name><surname>Ahlquist</surname><given-names>P</given-names></name> (<year>1988</year>) <source>RNA Genetics. Boca Raton: CRC Press</source>.</mixed-citation></ref><ref id="pgen.1008271.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Holland</surname><given-names>J</given-names></name> (<year>2006</year>) <article-title>Transitions in understanding of RNA viruses: an historical perspective</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>299</volume>: <fpage>371</fpage>&#x02013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1007/3-540-26397-7_14</pub-id>
<?supplied-pmid 16568907?><pub-id pub-id-type="pmid">16568907</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Sheldon</surname><given-names>J</given-names></name>, <name><surname>Perales</surname><given-names>C</given-names></name> (<year>2012</year>) <article-title>Viral quasispecies evolution</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>76</volume>: <fpage>159</fpage>&#x02013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.05023-11</pub-id>
<?supplied-pmid 22688811?><pub-id pub-id-type="pmid">22688811</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Meyerhans</surname><given-names>A</given-names></name>, <name><surname>Cheynier</surname><given-names>R</given-names></name>, <name><surname>Albert</surname><given-names>J</given-names></name>, <name><surname>Seth</surname><given-names>M</given-names></name>, <name><surname>Kwok</surname><given-names>S</given-names></name>, <name><surname>Sninsky</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>1989</year>) <article-title>Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations</article-title>. <source>Cell</source>
<volume>58</volume>: <fpage>901</fpage>&#x02013;<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(89)90942-2</pub-id>
<?supplied-pmid 2550139?><pub-id pub-id-type="pmid">2550139</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Farci</surname><given-names>P</given-names></name> (<year>2011</year>) <article-title>New insights into the HCV quasispecies and compartmentalization</article-title>. <source>Semin Liver Dis</source>
<volume>31</volume>: <fpage>356</fpage>&#x02013;<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1055/s-0031-1297925</pub-id>
<?supplied-pmid 22189976?><pub-id pub-id-type="pmid">22189976</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Saakian</surname><given-names>DB</given-names></name>, <name><surname>Hu</surname><given-names>CK</given-names></name> (<year>2016</year>) <article-title>Mathematical Models of Quasi-Species Theory and Exact Results for the Dynamics</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>121</fpage>&#x02013;<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_471</pub-id>
<?supplied-pmid 26342705?><pub-id pub-id-type="pmid">26342705</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref020"><label>20</label><mixed-citation publication-type="book"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Schuster</surname><given-names>P</given-names></name> (<year>2016</year>) <chapter-title>Quasispecies: from theory to experimental systems</chapter-title>
<source>Current Topics in Microbiology and Immunology</source>. Vol. <volume>392</volume>
<publisher-name>Springer</publisher-name>.</mixed-citation></ref><ref id="pgen.1008271.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Steinhauer</surname><given-names>DA</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name> (<year>1992</year>) <article-title>Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase</article-title>. <source>Gene</source>
<volume>122</volume>: <fpage>281</fpage>&#x02013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1016/0378-1119(92)90216-c</pub-id>
<?supplied-pmid 1336756?><pub-id pub-id-type="pmid">1336756</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Bernad</surname><given-names>A</given-names></name>, <name><surname>Blanco</surname><given-names>L</given-names></name>, <name><surname>Lazaro</surname><given-names>JM</given-names></name>, <name><surname>Martin</surname><given-names>G</given-names></name>, <name><surname>Salas</surname><given-names>M</given-names></name> (<year>1989</year>) <article-title>A conserved 3'5' exonuclease active site in prokaryotic and eukaryotic DNA polymerases</article-title>. <source>Cell</source>
<volume>59</volume>: <fpage>219</fpage>&#x02013;<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(89)90883-0</pub-id>
<?supplied-pmid 2790959?><pub-id pub-id-type="pmid">2790959</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Eckerle</surname><given-names>LD</given-names></name>, <name><surname>Lu</surname><given-names>X</given-names></name>, <name><surname>Sperry</surname><given-names>SM</given-names></name>, <name><surname>Choi</surname><given-names>L</given-names></name>, <name><surname>Denison</surname><given-names>MR</given-names></name> (<year>2007</year>) <article-title>High fidelity of murine hepatitis virus replication is decreased in nsp14 exoribonuclease mutants</article-title>. <source>J Virol</source>
<volume>81</volume>: <fpage>12135</fpage>&#x02013;<lpage>12144</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.01296-07</pub-id>
<?supplied-pmid 17804504?><pub-id pub-id-type="pmid">17804504</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Nagy</surname><given-names>PD</given-names></name>, <name><surname>Carpenter</surname><given-names>CD</given-names></name>, <name><surname>Simon</surname><given-names>AE</given-names></name> (<year>1997</year>) <article-title>A novel 3'-end repair mechanism in an RNA virus</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>94</volume>: <fpage>1113</fpage>&#x02013;<lpage>1118</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.4.1113</pub-id>
<?supplied-pmid 9037015?><pub-id pub-id-type="pmid">9037015</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Bakhanashvili</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Exonucleolytic proofreading by p53 protein</article-title>. <source>Eur J Biochem</source>
<volume>268</volume>: <fpage>2047</fpage>&#x02013;<lpage>2054</lpage>. <pub-id pub-id-type="doi">10.1046/j.1432-1327.2001.02075.x</pub-id>
<?supplied-pmid 11277927?><pub-id pub-id-type="pmid">11277927</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>EC</given-names></name>, <name><surname>Denison</surname><given-names>MR</given-names></name> (<year>2013</year>) <article-title>Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity</article-title>. <source>PLoS Pathog</source>
<volume>9</volume>: <fpage>e1003760</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1003760</pub-id>
<?supplied-pmid 24348241?><pub-id pub-id-type="pmid">24348241</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>EC</given-names></name>, <name><surname>Sexton</surname><given-names>NR</given-names></name>, <name><surname>Denison</surname><given-names>MR</given-names></name> (<year>2014</year>) <article-title>Thinking Outside the Triangle: Replication Fidelity of the Largest RNA Viruses</article-title>. <source>Annu Rev Virol</source>
<volume>1</volume>: <fpage>111</fpage>&#x02013;<lpage>132</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-virology-031413-085507</pub-id>
<?supplied-pmid 26958717?><pub-id pub-id-type="pmid">26958717</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Wagner</surname><given-names>N</given-names></name>, <name><surname>Atsmon-Raz</surname><given-names>Y</given-names></name>, <name><surname>Ashkenasy</surname><given-names>G</given-names></name> (<year>2016</year>) <article-title>Theoretical Models of Generalized Quasispecies</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>141</fpage>&#x02013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_456</pub-id>
<?supplied-pmid 26373410?><pub-id pub-id-type="pmid">26373410</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Schmidt</surname><given-names>TT</given-names></name>, <name><surname>Reyes</surname><given-names>G</given-names></name>, <name><surname>Gries</surname><given-names>K</given-names></name>, <name><surname>Ceylan</surname><given-names>CU</given-names></name>, <name><surname>Sharma</surname><given-names>S</given-names></name>, <name><surname>Meurer</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Alterations in cellular metabolism triggered by URA7 or GLN3 inactivation cause imbalanced dNTP pools and increased mutagenesis</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>114</volume>: <fpage>E4442</fpage>&#x02013;<lpage>E4451</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1618714114</pub-id>
<?supplied-pmid 28416670?><pub-id pub-id-type="pmid">28416670</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Takahashi</surname><given-names>K</given-names></name>, <name><surname>Sekizuka</surname><given-names>T</given-names></name>, <name><surname>Fukumoto</surname><given-names>H</given-names></name>, <name><surname>Nakamichi</surname><given-names>K</given-names></name>, <name><surname>Suzuki</surname><given-names>T</given-names></name>, <name><surname>Sato</surname><given-names>Y</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy</article-title>. <source>J Virol</source>
<volume>91</volume>.</mixed-citation></ref><ref id="pgen.1008271.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Domingo-Calap</surname><given-names>P</given-names></name>, <name><surname>Schubert</surname><given-names>B</given-names></name>, <name><surname>Joly</surname><given-names>M</given-names></name>, <name><surname>Solis</surname><given-names>M</given-names></name>, <name><surname>Untrau</surname><given-names>M</given-names></name>, <name><surname>Carapito</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>An unusually high substitution rate in transplant-associated BK polyomavirus in vivo is further concentrated in HLA-C-bound viral peptides</article-title>. <source>PLoS Pathog</source>
<volume>14</volume>: <fpage>e1007368</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007368</pub-id>
<?supplied-pmid 30335851?><pub-id pub-id-type="pmid">30335851</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Sanchez-Campos</surname><given-names>S</given-names></name>, <name><surname>Dominguez-Huerta</surname><given-names>G</given-names></name>, <name><surname>Diaz-Martinez</surname><given-names>L</given-names></name>, <name><surname>Tomas</surname><given-names>DM</given-names></name>, <name><surname>Navas-Castillo</surname><given-names>J</given-names></name>, <name><surname>Moriones</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Differential Shape of Geminivirus Mutant Spectra Across Cultivated and Wild Hosts With Invariant Viral Consensus Sequences</article-title>. <source>Front Plant Sci</source>
<volume>9</volume>: <fpage>932</fpage>
<pub-id pub-id-type="doi">10.3389/fpls.2018.00932</pub-id>
<?supplied-pmid 30013589?><pub-id pub-id-type="pmid">30013589</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Agol</surname><given-names>VI</given-names></name>, <name><surname>Gmyl</surname><given-names>AP</given-names></name> (<year>2018</year>) <article-title>Emergency Services of Viral RNAs: Repair and Remodeling</article-title>. <source>Microbiol Mol Biol Rev</source>
<volume>82</volume> pii: <fpage>e00067</fpage>&#x02013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00067-17</pub-id>
<?supplied-pmid 29540453?><pub-id pub-id-type="pmid">29540453</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Figlerowicz</surname><given-names>M</given-names></name>, <name><surname>Alejska</surname><given-names>M</given-names></name>, <name><surname>Kurzynska-Kokorniak</surname><given-names>A</given-names></name>, <name><surname>Figlerowicz</surname><given-names>M</given-names></name> (<year>2003</year>) <article-title>Genetic variability: the key problem in the prevention and therapy of RNA-based virus infections</article-title>. <source>Medicinal Res Reviews</source>
<volume>23</volume>: <fpage>488</fpage>&#x02013;<lpage>518</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Perales</surname><given-names>C</given-names></name> (<year>2018</year>) <article-title>Quasispecies and virus</article-title>. <source>Eur Biophys J</source>
<volume>47</volume>: <fpage>443</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1007/s00249-018-1282-6</pub-id>
<?supplied-pmid 29397419?><pub-id pub-id-type="pmid">29397419</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Sanjuan</surname><given-names>R</given-names></name>, <name><surname>Domingo-Calap</surname><given-names>P</given-names></name> (<year>2016</year>) <article-title>Mechanisms of viral mutation</article-title>. <source>Cell Mol Life Sci</source>
<volume>73</volume>: <fpage>4433</fpage>&#x02013;<lpage>4448</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-016-2299-6</pub-id>
<?supplied-pmid 27392606?><pub-id pub-id-type="pmid">27392606</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Lauring</surname><given-names>AS</given-names></name>, <name><surname>Andino</surname><given-names>R</given-names></name> (<year>2010</year>) <article-title>Quasispecies theory and the behavior of RNA viruses</article-title>. <source>PLoS Pathog</source>
<volume>6</volume>: <fpage>e1001005</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1001005</pub-id>
<?supplied-pmid 20661479?><pub-id pub-id-type="pmid">20661479</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>van Boheemen</surname><given-names>S</given-names></name>, <name><surname>Tas</surname><given-names>A</given-names></name>, <name><surname>Anvar</surname><given-names>SY</given-names></name>, <name><surname>van Grootveld</surname><given-names>R</given-names></name>, <name><surname>Albulescu</surname><given-names>IC</given-names></name>, <name><surname>Bauer</surname><given-names>MP</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Quasispecies composition and evolution of a typical Zika virus clinical isolate from Suriname</article-title>. <source>Sci Rep</source>
<volume>7</volume>: <fpage>2368</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-02652-w</pub-id>
<?supplied-pmid 28539654?><pub-id pub-id-type="pmid">28539654</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Vlok</surname><given-names>M</given-names></name>, <name><surname>Lang</surname><given-names>AS</given-names></name>, <name><surname>Suttle</surname><given-names>CA</given-names></name> (<year>2019</year>) <article-title>Marine RNA Virus Quasispecies Are Distributed throughout the Oceans</article-title>. <source>mSphere</source>
<volume>4</volume> pii: <fpage>e00157</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1128/mSphereDirect.00157-19</pub-id>
<?supplied-pmid 30944212?><pub-id pub-id-type="pmid">30944212</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Hirose</surname><given-names>Y</given-names></name>, <name><surname>Onuki</surname><given-names>M</given-names></name>, <name><surname>Tenjimbayashi</surname><given-names>Y</given-names></name>, <name><surname>Mori</surname><given-names>S</given-names></name>, <name><surname>Ishii</surname><given-names>Y</given-names></name>, <name><surname>Takeuchi</surname><given-names>T</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Within-Host Variations of Human Papillomavirus Reveal APOBEC Signature Mutagenesis in the Viral Genome</article-title>. <source>J Virol</source>
<volume>92</volume> pii: <fpage>e00017</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.00017-18</pub-id>
<?supplied-pmid 29593040?><pub-id pub-id-type="pmid">29593040</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Gisder</surname><given-names>S</given-names></name>, <name><surname>Mockel</surname><given-names>N</given-names></name>, <name><surname>Eisenhardt</surname><given-names>D</given-names></name>, <name><surname>Genersch</surname><given-names>E</given-names></name> (<year>2018</year>) <article-title>In vivo evolution of viral virulence: switching of deformed wing virus between hosts results in virulence changes and sequence shifts</article-title>. <source>Environ Microbiol</source>
<volume>20</volume>: <fpage>4612</fpage>&#x02013;<lpage>4628</lpage>. <pub-id pub-id-type="doi">10.1111/1462-2920.14481</pub-id>
<?supplied-pmid 30452113?><pub-id pub-id-type="pmid">30452113</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Baccam</surname><given-names>P</given-names></name>, <name><surname>Thompson</surname><given-names>RJ</given-names></name>, <name><surname>Fedrigo</surname><given-names>O</given-names></name>, <name><surname>Carpenter</surname><given-names>S</given-names></name>, <name><surname>Cornette</surname><given-names>JL</given-names></name> (<year>2001</year>) <article-title>PAQ: Partition Analysis of Quasispecies</article-title>. <source>Bioinformatics</source>
<volume>17</volume>: <fpage>16</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/17.1.16</pub-id>
<?supplied-pmid 11222259?><pub-id pub-id-type="pmid">11222259</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Skums</surname><given-names>P</given-names></name>, <name><surname>Zelikovsky</surname><given-names>A</given-names></name>, <name><surname>Singh</surname><given-names>R</given-names></name>, <name><surname>Gussler</surname><given-names>W</given-names></name>, <name><surname>Dimitrova</surname><given-names>Z</given-names></name>, <name><surname>Knyazev</surname><given-names>S</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>QUENTIN: reconstruction of disease transmissions from viral quasispecies genomic data</article-title>. <source>Bioinformatics</source>
<volume>34</volume>: <fpage>163</fpage>&#x02013;<lpage>170</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btx402</pub-id>
<?supplied-pmid 29304222?><pub-id pub-id-type="pmid">29304222</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Lowry</surname><given-names>K</given-names></name>, <name><surname>Woodman</surname><given-names>A</given-names></name>, <name><surname>Cook</surname><given-names>J</given-names></name>, <name><surname>Evans</surname><given-names>DJ</given-names></name> (<year>2014</year>) <article-title>Recombination in enteroviruses is a biphasic replicative process involving the generation of greater-than genome length 'imprecise' intermediates</article-title>. <source>PLoS Pathog</source>
<volume>10</volume>: <fpage>e1004191</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1004191</pub-id>
<?supplied-pmid 24945141?><pub-id pub-id-type="pmid">24945141</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Rouzine</surname><given-names>IM</given-names></name>, <name><surname>Bianco</surname><given-names>S</given-names></name>, <name><surname>Acevedo</surname><given-names>A</given-names></name>, <name><surname>Goldstein</surname><given-names>EF</given-names></name>, <name><surname>Farkov</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>RNA Recombination Enhances Adaptability and Is Required for Virus Spread and Virulence</article-title>. <source>Cell Host Microbe</source>
<volume>22</volume>: <fpage>420</fpage>
<pub-id pub-id-type="doi">10.1016/j.chom.2017.08.006</pub-id>
<?supplied-pmid 28910639?><pub-id pub-id-type="pmid">28910639</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Tibayrenc</surname><given-names>M</given-names></name>, <name><surname>Ayala</surname><given-names>FJ</given-names></name> (<year>2012</year>) <article-title>Reproductive clonality of pathogens: a perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>E3305</fpage>&#x02013;<lpage>3313</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1212452109</pub-id>
<?supplied-pmid 22949662?><pub-id pub-id-type="pmid">22949662</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Perales</surname><given-names>C</given-names></name>, <name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2015</year>) <article-title>Clonality and intracellular polyploidy in virus evolution and pathogenesis</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>112</volume>: <fpage>8887</fpage>&#x02013;<lpage>8892</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1501715112</pub-id>
<?supplied-pmid 26195777?><pub-id pub-id-type="pmid">26195777</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Villarreal</surname><given-names>LP</given-names></name>, <name><surname>Witzany</surname><given-names>G</given-names></name> (<year>2013</year>) <article-title>Rethinking quasispecies theory: From fittest type to cooperative consortia</article-title>. <source>World J Biol Chem</source>
<volume>4</volume>: <fpage>79</fpage>&#x02013;<lpage>90</lpage>. <pub-id pub-id-type="doi">10.4331/wjbc.v4.i4.79</pub-id>
<?supplied-pmid 24340131?><pub-id pub-id-type="pmid">24340131</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref049"><label>49</label><mixed-citation publication-type="book"><name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2020</year>) <source>Virus as Populations</source>, <edition>2nd ed</edition>
<publisher-name>Academic Press, Elsevier</publisher-name>, <publisher-loc>Amsterdam</publisher-loc>.</mixed-citation></ref><ref id="pgen.1008271.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Acevedo</surname><given-names>A</given-names></name>, <name><surname>Brodsky</surname><given-names>L</given-names></name>, <name><surname>Andino</surname><given-names>R</given-names></name> (<year>2014</year>) <article-title>Mutational and fitness landscapes of an RNA virus revealed through population sequencing</article-title>. <source>Nature</source>
<volume>505</volume>: <fpage>686</fpage>&#x02013;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1038/nature12861</pub-id>
<?supplied-pmid 24284629?><pub-id pub-id-type="pmid">24284629</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Gallego</surname><given-names>I</given-names></name>, <name><surname>Gregori</surname><given-names>J</given-names></name>, <name><surname>Lucia-Sanz</surname><given-names>A</given-names></name>, <name><surname>Soria</surname><given-names>ME</given-names></name>, <name><surname>Castro</surname><given-names>V</given-names></name>, <etal>et al</etal> (<year>2017</year>) <article-title>Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment</article-title>. <source>J Virol</source>
<volume>91</volume>:<fpage>e02505</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.02505-16</pub-id>
<?supplied-pmid 28275194?><pub-id pub-id-type="pmid">28275194</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Braun</surname><given-names>T</given-names></name>, <name><surname>Borderia</surname><given-names>AV</given-names></name>, <name><surname>Barbezange</surname><given-names>C</given-names></name>, <name><surname>Vignuzzi</surname><given-names>M</given-names></name>, <name><surname>Louzon</surname><given-names>Y</given-names></name> (<year>2019</year>) <article-title>Long-term context dependent genetic adaptation of the viral genetic cloud</article-title>. <source>Bioinformatics</source>. <volume>35</volume>:<fpage>1907</fpage>&#x02013;<lpage>1915</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/bty891</pub-id>
<?supplied-pmid 30346482?><pub-id pub-id-type="pmid">30346482</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Ojosnegros</surname><given-names>S</given-names></name>, <name><surname>Beerenwinkel</surname><given-names>N</given-names></name>, <name><surname>Antal</surname><given-names>T</given-names></name>, <name><surname>Nowak</surname><given-names>MA</given-names></name>, <name><surname>Escarmis</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2010</year>) <article-title>Competition-colonization dynamics in an RNA virus</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>107</volume>: <fpage>2108</fpage>&#x02013;<lpage>2112</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0909787107</pub-id>
<?supplied-pmid 20080701?><pub-id pub-id-type="pmid">20080701</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Gallego</surname><given-names>I</given-names></name>, <name><surname>Gregori</surname><given-names>J</given-names></name>, <name><surname>Soria</surname><given-names>ME</given-names></name>, <name><surname>Garcia-Crespo</surname><given-names>C</given-names></name>, <name><surname>Garcia-Alvarez</surname><given-names>M</given-names></name>, <name><surname>Gomez-Gonzalez</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Resistance of high fitness hepatitis C virus to lethal mutagenesis</article-title>. <source>Virology</source>
<volume>523</volume>: <fpage>100</fpage>&#x02013;<lpage>109</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2018.07.030</pub-id>
<?supplied-pmid 30107298?><pub-id pub-id-type="pmid">30107298</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Holland</surname><given-names>JJ</given-names></name>, <name><surname>de La Torre</surname><given-names>JC</given-names></name>, <name><surname>Steinhauer</surname><given-names>DA</given-names></name> (<year>1992</year>) <article-title>RNA virus populations as quasispecies</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>176</volume>: <fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-Arriaza</surname><given-names>J</given-names></name>, <name><surname>Ojosnegros</surname><given-names>S</given-names></name>, <name><surname>D&#x000e1;vila</surname><given-names>M</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Escarmis</surname><given-names>C</given-names></name> (<year>2006</year>) <article-title>Dynamics of mutation and recombination in a replicating population of complementing, defective viral genomes</article-title>. <source>J Mol Biol</source>
<volume>360</volume>: <fpage>558</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2006.05.027</pub-id>
<?supplied-pmid 16797586?><pub-id pub-id-type="pmid">16797586</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref057"><label>57</label><mixed-citation publication-type="journal"><name><surname>Briones</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2008</year>) <article-title>Minority report: hidden memory genomes in HIV-1 quasispecies and possible clinical implications</article-title>. <source>AIDS Rev</source>
<volume>10</volume>: <fpage>93</fpage>&#x02013;<lpage>109</lpage>. <?supplied-pmid 18615120?><pub-id pub-id-type="pmid">18615120</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref058"><label>58</label><mixed-citation publication-type="journal"><name><surname>Chumakov</surname><given-names>KM</given-names></name>, <name><surname>Powers</surname><given-names>LB</given-names></name>, <name><surname>Noonan</surname><given-names>KE</given-names></name>, <name><surname>Roninson</surname><given-names>IB</given-names></name>, <name><surname>Levenbook</surname><given-names>IS</given-names></name> (<year>1991</year>) <article-title>Correlation between amount of virus with altered nucleotide sequence and the monkey test for acceptability of oral poliovirus vaccine</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>88</volume>: <fpage>199</fpage>&#x02013;<lpage>203</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.1.199</pub-id>
<?supplied-pmid 1846038?><pub-id pub-id-type="pmid">1846038</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref059"><label>59</label><mixed-citation publication-type="book"><name><surname>Holland</surname><given-names>JJ</given-names></name>, editor (<year>1992</year>) <chapter-title>Genetic diversity of RNA viruses</chapter-title>
<source>Current Topics in Microbiology and Immunology</source>. <publisher-loc>Berlin</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>.</mixed-citation></ref><ref id="pgen.1008271.ref060"><label>60</label><mixed-citation publication-type="journal"><name><surname>Perales</surname><given-names>C</given-names></name> (<year>2018</year>) <article-title>Quasispecies dynamics and clinical significance of hepatitis C virus (HCV) antiviral resistance</article-title>. <source>Int J Antimicrob Agents</source>. <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2018.10.005</pub-id>
<?supplied-pmid 30315919?><pub-id pub-id-type="pmid">30315919</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref061"><label>61</label><mixed-citation publication-type="journal"><name><surname>Donohue</surname><given-names>RC</given-names></name>, <name><surname>Pfaller</surname><given-names>CK</given-names></name>, <name><surname>Cattaneo</surname><given-names>R</given-names></name> (<year>2019</year>) <article-title>Cyclical adaptation of measles virus quasispecies to epithelial and lymphocytic cells: To V, or not to V</article-title>. <source>PLoS Pathog</source>
<volume>15</volume>: <fpage>e1007605</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1007605</pub-id>
<?supplied-pmid 30768648?><pub-id pub-id-type="pmid">30768648</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref062"><label>62</label><mixed-citation publication-type="journal"><name><surname>Martin</surname><given-names>V</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2008</year>) <article-title>Influence of the mutant spectrum in viral evolution: focused selection of antigenic variants in a reconstructed viral quasispecies</article-title>. <source>Mol Biol Evol</source>
<volume>25</volume>: <fpage>1544</fpage>&#x02013;<lpage>1554</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msn099</pub-id>
<?supplied-pmid 18436553?><pub-id pub-id-type="pmid">18436553</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref063"><label>63</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Jarabo</surname><given-names>CM</given-names></name>, <name><surname>Arias</surname><given-names>A</given-names></name>, <name><surname>Baranowski</surname><given-names>E</given-names></name>, <name><surname>Escarm&#x000ed;s</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2000</year>) <article-title>Memory in viral quasispecies</article-title>. <source>J Virol</source>
<volume>74</volume>: <fpage>3543</fpage>&#x02013;<lpage>3547</lpage>. <pub-id pub-id-type="doi">10.1128/jvi.74.8.3543-3547.2000</pub-id>
<?supplied-pmid 10729128?><pub-id pub-id-type="pmid">10729128</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref064"><label>64</label><mixed-citation publication-type="journal"><name><surname>Farber</surname><given-names>DL</given-names></name>, <name><surname>Netea</surname><given-names>MG</given-names></name>, <name><surname>Radbruch</surname><given-names>A</given-names></name>, <name><surname>Rajewsky</surname><given-names>K</given-names></name>, <name><surname>Zinkernagel</surname><given-names>RM</given-names></name> (<year>2016</year>) <article-title>Immunological memory: lessons from the past and a look to the future</article-title>. <source>Nat Rev Immunol</source>
<volume>16</volume>: <fpage>124</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1038/nri.2016.13</pub-id>
<?supplied-pmid 26831526?><pub-id pub-id-type="pmid">26831526</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref065"><label>65</label><mixed-citation publication-type="journal"><name><surname>Briones</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Molina-Par&#x000ed;s</surname><given-names>C</given-names></name> (<year>2003</year>) <article-title>Memory in retroviral quasispecies: experimental evidence and theoretical model for human immunodeficiency virus</article-title>. <source>J Mol Biol</source>
<volume>331</volume>: <fpage>213</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1016/s0022-2836(03)00661-2</pub-id>
<?supplied-pmid 12875847?><pub-id pub-id-type="pmid">12875847</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref066"><label>66</label><mixed-citation publication-type="journal"><name><surname>Arias</surname><given-names>A</given-names></name>, <name><surname>Ruiz-Jarabo</surname><given-names>CM</given-names></name>, <name><surname>Escarmis</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2004</year>) <article-title>Fitness increase of memory genomes in a viral quasispecies</article-title>. <source>J Mol Biol</source>
<volume>339</volume>: <fpage>405</fpage>&#x02013;<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2004.03.061</pub-id>
<?supplied-pmid 15136042?><pub-id pub-id-type="pmid">15136042</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref067"><label>67</label><mixed-citation publication-type="book"><name><surname>Eigen</surname><given-names>M</given-names></name>, <name><surname>Biebricher</surname><given-names>CK</given-names></name> (<year>1988</year>) <chapter-title>Sequence space and quasispecies distribution</chapter-title> In: <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Ahlquist</surname><given-names>P</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name>, editors. <source>RNA Genetics</source>: <publisher-loc>Boca Raton, FL</publisher-loc>
<publisher-name>CRC Press</publisher-name> pp. <fpage>211</fpage>&#x02013;<lpage>245</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref068"><label>68</label><mixed-citation publication-type="journal"><name><surname>de la Torre</surname><given-names>JC</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name> (<year>1990</year>) <article-title>RNA virus quasispecies populations can suppress vastly superior mutant progeny</article-title>. <source>J Virol</source>
<volume>64</volume>: <fpage>6278</fpage>&#x02013;<lpage>6281</lpage>. <?supplied-pmid 2173792?><pub-id pub-id-type="pmid">2173792</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref069"><label>69</label><mixed-citation publication-type="journal"><name><surname>Borrego</surname><given-names>B</given-names></name>, <name><surname>Novella</surname><given-names>IS</given-names></name>, <name><surname>Giralt</surname><given-names>E</given-names></name>, <name><surname>Andreu</surname><given-names>D</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>1993</year>) <article-title>Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection</article-title>. <source>J Virol</source>
<volume>67</volume>: <fpage>6071</fpage>&#x02013;<lpage>6079</lpage>. <?supplied-pmid 7690417?><pub-id pub-id-type="pmid">7690417</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref070"><label>70</label><mixed-citation publication-type="journal"><name><surname>Teng</surname><given-names>MN</given-names></name>, <name><surname>Oldstone</surname><given-names>MB</given-names></name>, <name><surname>de la Torre</surname><given-names>JC</given-names></name> (<year>1996</year>) <article-title>Suppression of lymphocytic choriomeningitis virus-induced growth hormone deficiency syndrome by disease-negative virus variants</article-title>. <source>Virology</source>
<volume>223</volume>: <fpage>113</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1006/viro.1996.0460</pub-id>
<?supplied-pmid 8806545?><pub-id pub-id-type="pmid">8806545</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref071"><label>71</label><mixed-citation publication-type="journal"><name><surname>Gonz&#x000e1;lez-L&#x000f3;pez</surname><given-names>C</given-names></name>, <name><surname>Arias</surname><given-names>A</given-names></name>, <name><surname>Pariente</surname><given-names>N</given-names></name>, <name><surname>G&#x000f3;mez-Mariano</surname><given-names>G</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2004</year>) <article-title>Preextinction viral RNA can interfere with infectivity</article-title>. <source>J Virol</source>
<volume>78</volume>: <fpage>3319</fpage>&#x02013;<lpage>3324</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.7.3319-3324.2004</pub-id>
<?supplied-pmid 15016853?><pub-id pub-id-type="pmid">15016853</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref072"><label>72</label><mixed-citation publication-type="journal"><name><surname>Perales</surname><given-names>C</given-names></name>, <name><surname>Mateo</surname><given-names>R</given-names></name>, <name><surname>Mateu</surname><given-names>MG</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>Insights into RNA virus mutant spectrum and lethal mutagenesis events: replicative interference and complementation by multiple point mutants</article-title>. <source>J Mol Biol</source>
<volume>369</volume>: <fpage>985</fpage>&#x02013;<lpage>1000</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmb.2007.03.074</pub-id>
<?supplied-pmid 17481660?><pub-id pub-id-type="pmid">17481660</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref073"><label>73</label><mixed-citation publication-type="journal"><name><surname>Crowder</surname><given-names>S</given-names></name>, <name><surname>Kirkegaard</surname><given-names>K</given-names></name> (<year>2005</year>) <article-title>Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses</article-title>. <source>Nat Genet</source>
<volume>37</volume>: <fpage>701</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1038/ng1583</pub-id>
<?supplied-pmid 15965477?><pub-id pub-id-type="pmid">15965477</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref074"><label>74</label><mixed-citation publication-type="journal"><name><surname>Kirkegaard</surname><given-names>K</given-names></name>, <name><surname>van Buuren</surname><given-names>NJ</given-names></name>, <name><surname>Mateo</surname><given-names>R</given-names></name> (<year>2016</year>) <article-title>My Cousin, My Enemy: quasispecies suppression of drug resistance</article-title>. <source>Curr Opin Virol</source>
<volume>20</volume>: <fpage>106</fpage>&#x02013;<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2016.09.011</pub-id>
<?supplied-pmid 27764731?><pub-id pub-id-type="pmid">27764731</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref075"><label>75</label><mixed-citation publication-type="journal"><name><surname>Wilke</surname><given-names>CO</given-names></name>, <name><surname>Wang</surname><given-names>JL</given-names></name>, <name><surname>Ofria</surname><given-names>C</given-names></name>, <name><surname>Lenski</surname><given-names>RE</given-names></name>, <name><surname>Adami</surname><given-names>C</given-names></name> (<year>2001</year>) <article-title>Evolution of digital organisms at high mutation rates leads to survival of the flattest</article-title>. <source>Nature</source>
<volume>412</volume>: <fpage>331</fpage>&#x02013;<lpage>333</lpage>. <pub-id pub-id-type="doi">10.1038/35085569</pub-id>
<?supplied-pmid 11460163?><pub-id pub-id-type="pmid">11460163</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref076"><label>76</label><mixed-citation publication-type="journal"><name><surname>Quer</surname><given-names>J</given-names></name>, <name><surname>Hershey</surname><given-names>CL</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Holland</surname><given-names>JJ</given-names></name>, <name><surname>Novella</surname><given-names>IS</given-names></name> (<year>2001</year>) <article-title>Contingent neutrality in competing viral populations</article-title>. <source>J Virol</source>
<volume>75</volume>: <fpage>7315</fpage>&#x02013;<lpage>7320</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.75.16.7315-7320.2001</pub-id>
<?supplied-pmid 11462003?><pub-id pub-id-type="pmid">11462003</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref077"><label>77</label><mixed-citation publication-type="journal"><name><surname>Codoner</surname><given-names>FM</given-names></name>, <name><surname>Daros</surname><given-names>JA</given-names></name>, <name><surname>Sole</surname><given-names>RV</given-names></name>, <name><surname>Elena</surname><given-names>SF</given-names></name> (<year>2006</year>) <article-title>The fittest versus the flattest: experimental confirmation of the quasispecies effect with subviral pathogens</article-title>. <source>PLoS Pathog</source>
<volume>2</volume>: <fpage>e136</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.0020136</pub-id>
<?supplied-pmid 17196038?><pub-id pub-id-type="pmid">17196038</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref078"><label>78</label><mixed-citation publication-type="journal"><name><surname>Tejero</surname><given-names>H</given-names></name>, <name><surname>Montero</surname><given-names>F</given-names></name>, <name><surname>Nuno</surname><given-names>JC</given-names></name> (<year>2016</year>) <article-title>Theories of Lethal Mutagenesis: From Error Catastrophe to Lethal Defection</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>161</fpage>&#x02013;<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_463</pub-id>
<?supplied-pmid 26210988?><pub-id pub-id-type="pmid">26210988</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref079"><label>79</label><mixed-citation publication-type="journal"><name><surname>Pfeiffer</surname><given-names>JK</given-names></name>, <name><surname>Kirkegaard</surname><given-names>K</given-names></name> (<year>2005</year>) <article-title>Increased fidelity reduces poliovirus fitness under selective pressure in mice</article-title>. <source>PLoS Pathogens</source>
<volume>1</volume>: <fpage>102</fpage>&#x02013;<lpage>110</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref080"><label>80</label><mixed-citation publication-type="journal"><name><surname>Vignuzzi</surname><given-names>M</given-names></name>, <name><surname>Stone</surname><given-names>JK</given-names></name>, <name><surname>Arnold</surname><given-names>JJ</given-names></name>, <name><surname>Cameron</surname><given-names>CE</given-names></name>, <name><surname>Andino</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population</article-title>. <source>Nature</source>
<volume>439</volume>: <fpage>344</fpage>&#x02013;<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/nature04388</pub-id>
<?supplied-pmid 16327776?><pub-id pub-id-type="pmid">16327776</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref081"><label>81</label><mixed-citation publication-type="journal"><name><surname>Borderia</surname><given-names>AV</given-names></name>, <name><surname>Rozen-Gagnon</surname><given-names>K</given-names></name>, <name><surname>Vignuzzi</surname><given-names>M</given-names></name> (<year>2016</year>) <article-title>Fidelity Variants and RNA Quasispecies</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>303</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_483</pub-id>
<?supplied-pmid 26499340?><pub-id pub-id-type="pmid">26499340</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref082"><label>82</label><mixed-citation publication-type="journal"><name><surname>Garc&#x000ed;a-Arriaza</surname><given-names>J</given-names></name>, <name><surname>Manrubia</surname><given-names>SC</given-names></name>, <name><surname>Toja</surname><given-names>M</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Escarm&#x000ed;s</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Evolutionary transition toward defective RNAs that are infectious by complementation</article-title>. <source>J Virol</source>
<volume>78</volume>: <fpage>11678</fpage>&#x02013;<lpage>11685</lpage>. <pub-id pub-id-type="doi">10.1128/JVI.78.21.11678-11685.2004</pub-id>
<?supplied-pmid 15479809?><pub-id pub-id-type="pmid">15479809</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref083"><label>83</label><mixed-citation publication-type="journal"><name><surname>Moreno</surname><given-names>E</given-names></name>, <name><surname>Ojosnegros</surname><given-names>S</given-names></name>, <name><surname>Garcia-Arriaza</surname><given-names>J</given-names></name>, <name><surname>Escarmis</surname><given-names>C</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Perales</surname><given-names>C</given-names></name> (<year>2014</year>) <article-title>Exploration of sequence space as the basis of viral RNA genome segmentation</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>111</volume>: <fpage>6678</fpage>&#x02013;<lpage>6683</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1323136111</pub-id>
<?supplied-pmid 24757055?><pub-id pub-id-type="pmid">24757055</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref084"><label>84</label><mixed-citation publication-type="journal"><name><surname>Aaskov</surname><given-names>J</given-names></name>, <name><surname>Buzacott</surname><given-names>K</given-names></name>, <name><surname>Thu</surname><given-names>HM</given-names></name>, <name><surname>Lowry</surname><given-names>K</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name> (<year>2006</year>) <article-title>Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes</article-title>. <source>Science</source>
<volume>311</volume>: <fpage>236</fpage>&#x02013;<lpage>238</lpage>. <pub-id pub-id-type="doi">10.1126/science.1115030</pub-id>
<?supplied-pmid 16410525?><pub-id pub-id-type="pmid">16410525</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref085"><label>85</label><mixed-citation publication-type="journal"><name><surname>Ciota</surname><given-names>AT</given-names></name>, <name><surname>Ehrbar</surname><given-names>DJ</given-names></name>, <name><surname>Van Slyke</surname><given-names>GA</given-names></name>, <name><surname>Willsey</surname><given-names>GG</given-names></name>, <name><surname>Kramer</surname><given-names>LD</given-names></name> (<year>2012</year>) <article-title>Cooperative interactions in the West Nile virus mutant swarm</article-title>. <source>BMC Evol Biol</source>
<volume>12</volume>: <fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2148-12-58</pub-id>
<?supplied-pmid 22541042?><pub-id pub-id-type="pmid">22541042</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref086"><label>86</label><mixed-citation publication-type="journal"><name><surname>Xue</surname><given-names>KS</given-names></name>, <name><surname>Hooper</surname><given-names>KA</given-names></name>, <name><surname>Ollodart</surname><given-names>AR</given-names></name>, <name><surname>Dingens</surname><given-names>AS</given-names></name>, <name><surname>Bloom</surname><given-names>JD</given-names></name> (<year>2016</year>) <article-title>Cooperation between distinct viral variants promotes growth of H3N2 influenza in cell culture</article-title>. <source>Elife</source>
<volume>5</volume>: <fpage>e13974</fpage>
<pub-id pub-id-type="doi">10.7554/eLife.13974</pub-id>
<?supplied-pmid 26978794?><pub-id pub-id-type="pmid">26978794</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref087"><label>87</label><mixed-citation publication-type="journal"><name><surname>Shirogane</surname><given-names>Y</given-names></name>, <name><surname>Watanabe</surname><given-names>S</given-names></name>, <name><surname>Yanagi</surname><given-names>Y</given-names></name> (<year>2016</year>) <article-title>Cooperative Interaction Within RNA Virus Mutant Spectra</article-title>. <source>Curr Top Microbiol Immunol</source>
<volume>392</volume>: <fpage>219</fpage>&#x02013;<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1007/82_2015_461</pub-id>
<?supplied-pmid 26162566?><pub-id pub-id-type="pmid">26162566</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref088"><label>88</label><mixed-citation publication-type="journal"><name><surname>Pfeiffer</surname><given-names>JK</given-names></name>, <name><surname>Kirkegaard</surname><given-names>K</given-names></name> (<year>2006</year>) <article-title>Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>103</volume>: <fpage>5520</fpage>&#x02013;<lpage>5525</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0600834103</pub-id>
<?supplied-pmid 16567621?><pub-id pub-id-type="pmid">16567621</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref089"><label>89</label><mixed-citation publication-type="journal"><name><surname>Gutierrez</surname><given-names>S</given-names></name>, <name><surname>Michalakis</surname><given-names>Y</given-names></name>, <name><surname>Blanc</surname><given-names>S</given-names></name> (<year>2012</year>) <article-title>Virus population bottlenecks during within-host progression and host-to-host transmission</article-title>. <source>Curr Opin Virol</source>
<volume>2</volume>: <fpage>546</fpage>&#x02013;<lpage>555</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2012.08.001</pub-id>
<?supplied-pmid 22921636?><pub-id pub-id-type="pmid">22921636</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref090"><label>90</label><mixed-citation publication-type="journal"><name><surname>Bull</surname><given-names>RA</given-names></name>, <name><surname>Luciani</surname><given-names>F</given-names></name>, <name><surname>McElroy</surname><given-names>K</given-names></name>, <name><surname>Gaudieri</surname><given-names>S</given-names></name>, <name><surname>Pham</surname><given-names>ST</given-names></name>, <name><surname>Chopra</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection</article-title>. <source>PLoS Pathog</source>
<volume>7</volume>: <fpage>e1002243</fpage>
<pub-id pub-id-type="doi">10.1371/journal.ppat.1002243</pub-id>
<?supplied-pmid 21912520?><pub-id pub-id-type="pmid">21912520</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref091"><label>91</label><mixed-citation publication-type="journal"><name><surname>Chao</surname><given-names>L</given-names></name> (<year>1990</year>) <article-title>Fitness of RNA virus decreased by Muller's ratchet</article-title>. <source>Nature</source>
<volume>348</volume>: <fpage>454</fpage>&#x02013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1038/348454a0</pub-id>
<?supplied-pmid 2247152?><pub-id pub-id-type="pmid">2247152</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref092"><label>92</label><mixed-citation publication-type="journal"><name><surname>Duarte</surname><given-names>E</given-names></name>, <name><surname>Clarke</surname><given-names>D</given-names></name>, <name><surname>Moya</surname><given-names>A</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <name><surname>Holland</surname><given-names>J</given-names></name> (<year>1992</year>) <article-title>Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>89</volume>: <fpage>6015</fpage>&#x02013;<lpage>6019</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.13.6015</pub-id>
<?supplied-pmid 1321432?><pub-id pub-id-type="pmid">1321432</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref093"><label>93</label><mixed-citation publication-type="journal"><name><surname>Muller</surname><given-names>HJ</given-names></name> (<year>1964</year>) <article-title>The relation of recombination to mutational advance</article-title>. <source>Mut Res</source>
<volume>1</volume>: <fpage>2</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="pgen.1008271.ref094"><label>94</label><mixed-citation publication-type="journal"><name><surname>Escarm&#x000ed;s</surname><given-names>C</given-names></name>, <name><surname>D&#x000e1;vila</surname><given-names>M</given-names></name>, <name><surname>Charpentier</surname><given-names>N</given-names></name>, <name><surname>Bracho</surname><given-names>A</given-names></name>, <name><surname>Moya</surname><given-names>A</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>1996</year>) <article-title>Genetic lesions associated with Muller's ratchet in an RNA virus</article-title>. <source>J Mol Biol</source>
<volume>264</volume>: <fpage>255</fpage>&#x02013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1996.0639</pub-id>
<?supplied-pmid 8951375?><pub-id pub-id-type="pmid">8951375</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref095"><label>95</label><mixed-citation publication-type="journal"><name><surname>Escarm&#x000ed;s</surname><given-names>C</given-names></name>, <name><surname>D&#x000e1;vila</surname><given-names>M</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>1999</year>) <article-title>Multiple molecular pathways for fitness recovery of an RNA virus debilitated by operation of Muller's ratchet</article-title>. <source>J Mol Biol</source>
<volume>285</volume>: <fpage>495</fpage>&#x02013;<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1006/jmbi.1998.2366</pub-id>
<?supplied-pmid 9878424?><pub-id pub-id-type="pmid">9878424</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref096"><label>96</label><mixed-citation publication-type="journal"><name><surname>Ruiz-Jarabo</surname><given-names>CM</given-names></name>, <name><surname>Pariente</surname><given-names>N</given-names></name>, <name><surname>Baranowski</surname><given-names>E</given-names></name>, <name><surname>D&#x000e1;vila</surname><given-names>M</given-names></name>, <name><surname>G&#x000f3;mez-Mariano</surname><given-names>G</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2004</year>) <article-title>Expansion of host-cell tropism of foot-and-mouth disease virus despite replication in a constant environment</article-title>. <source>J Gen Virol</source>
<volume>85</volume>: <fpage>2289</fpage>&#x02013;<lpage>2297</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.80126-0</pub-id>
<?supplied-pmid 15269370?><pub-id pub-id-type="pmid">15269370</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref097"><label>97</label><mixed-citation publication-type="journal"><name><surname>Mart&#x000ed;nez</surname><given-names>MA</given-names></name>, <name><surname>Dopazo</surname><given-names>J</given-names></name>, <name><surname>Hernandez</surname><given-names>J</given-names></name>, <name><surname>Mateu</surname><given-names>MG</given-names></name>, <name><surname>Sobrino</surname><given-names>F</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name>, <etal>et al</etal> (<year>1992</year>) <article-title>Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades</article-title>. <source>J Virol</source>
<volume>66</volume>: <fpage>3557</fpage>&#x02013;<lpage>3565</lpage>. <?supplied-pmid 1316467?><pub-id pub-id-type="pmid">1316467</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref098"><label>98</label><mixed-citation publication-type="journal"><name><surname>Ho</surname><given-names>SY</given-names></name>, <name><surname>Duchene</surname><given-names>S</given-names></name>, <name><surname>Molak</surname><given-names>M</given-names></name>, <name><surname>Shapiro</surname><given-names>B</given-names></name> (<year>2015</year>) <article-title>Time-dependent estimates of molecular evolutionary rates: evidence and causes</article-title>. <source>Mol Ecol</source>
<volume>24</volume>: <fpage>6007</fpage>&#x02013;<lpage>6012</lpage>. <pub-id pub-id-type="doi">10.1111/mec.13450</pub-id>
<?supplied-pmid 26769402?><pub-id pub-id-type="pmid">26769402</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref099"><label>99</label><mixed-citation publication-type="journal"><name><surname>Domingo</surname><given-names>E</given-names></name> (<year>1989</year>) <article-title>RNA virus evolution and the control of viral disease</article-title>. <source>Progress in Drug Research</source>
<volume>33</volume>: <fpage>93</fpage>&#x02013;<lpage>133</lpage>. <?supplied-pmid 2687948?><pub-id pub-id-type="pmid">2687948</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref100"><label>100</label><mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>PD</given-names></name> (<year>2009</year>) <article-title>Darwinian interventions: taming pathogens through evolutionary ecology</article-title>. <source>Trends Parasitol</source>
<volume>26</volume>: <fpage>83</fpage>&#x02013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.pt.2009.11.009</pub-id>
<?supplied-pmid 20036799?><pub-id pub-id-type="pmid">20036799</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref101"><label>101</label><mixed-citation publication-type="book"><name><surname>Perales</surname><given-names>C</given-names></name>, <name><surname>Ortega-Prieto</surname><given-names>AM</given-names></name>, <name><surname>Beach</surname><given-names>NM</given-names></name>, <name><surname>Sheldon</surname><given-names>J</given-names></name>, <name><surname>Menendez-Arias</surname><given-names>L</given-names></name>, <name><surname>Domingo</surname><given-names>E</given-names></name> (<year>2017</year>) <chapter-title>Quasispecies and drug resistance</chapter-title>
<source>Handbook of Antimicrobial Resistance</source>: <publisher-name>Springer Science+Business Media</publisher-name>
<publisher-loc>New York</publisher-loc> 2017.</mixed-citation></ref><ref id="pgen.1008271.ref102"><label>102</label><mixed-citation publication-type="journal"><name><surname>Loeb</surname><given-names>LA</given-names></name>, <name><surname>Essigmann</surname><given-names>JM</given-names></name>, <name><surname>Kazazi</surname><given-names>F</given-names></name>, <name><surname>Zhang</surname><given-names>J</given-names></name>, <name><surname>Rose</surname><given-names>KD</given-names></name>, <name><surname>Mullins</surname><given-names>JI</given-names></name> (<year>1999</year>) <article-title>Lethal mutagenesis of HIV with mutagenic nucleoside analogs</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>96</volume>: <fpage>1492</fpage>&#x02013;<lpage>1497</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.4.1492</pub-id>
<?supplied-pmid 9990051?><pub-id pub-id-type="pmid">9990051</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref103"><label>103</label><mixed-citation publication-type="journal"><name><surname>Perales</surname><given-names>C</given-names></name>, <name><surname>Gallego</surname><given-names>I</given-names></name>, <name><surname>De Avila</surname><given-names>AI</given-names></name>, <name><surname>Soria</surname><given-names>ME</given-names></name>, <name><surname>Gregori</surname><given-names>J</given-names></name>, <name><surname>Quer</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2019</year>) <article-title>The increasing impact of lethal mutagenesis of viruses</article-title>. <source>Future Med. Chem</source>. <volume>11</volume>(<issue>13</issue>): <fpage>1645</fpage>&#x02013;<lpage>1657</lpage>. <pub-id pub-id-type="doi">10.4155/fmc-2018-0457</pub-id>
<?supplied-pmid 31469331?><pub-id pub-id-type="pmid">31469331</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref104"><label>104</label><mixed-citation publication-type="journal"><name><surname>Eigen</surname><given-names>M</given-names></name> (<year>2002</year>) <article-title>Error catastrophe and antiviral strategy</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>99</volume>: <fpage>13374</fpage>&#x02013;<lpage>13376</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.212514799</pub-id>
<?supplied-pmid 12370416?><pub-id pub-id-type="pmid">12370416</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref105"><label>105</label><mixed-citation publication-type="journal"><name><surname>Venkatesan</surname><given-names>S</given-names></name>, <name><surname>Rosenthal</surname><given-names>R</given-names></name>, <name><surname>Kanu</surname><given-names>N</given-names></name>, <name><surname>McGranahan</surname><given-names>N</given-names></name>, <name><surname>Bartek</surname><given-names>J</given-names></name>, <name><surname>Quezada</surname><given-names>SA</given-names></name>, <etal>et al</etal> (<year>2018</year>) <article-title>Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution</article-title>. <source>Ann Oncol</source>
<volume>29</volume>: <fpage>563</fpage>&#x02013;<lpage>572</lpage>. <pub-id pub-id-type="doi">10.1093/annonc/mdy003</pub-id>
<?supplied-pmid 29324969?><pub-id pub-id-type="pmid">29324969</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref106"><label>106</label><mixed-citation publication-type="journal"><name><surname>Fox</surname><given-names>EJ</given-names></name>, <name><surname>Loeb</surname><given-names>LA</given-names></name> (<year>2010</year>) <article-title>Lethal mutagenesis: targeting the mutator phenotype in cancer</article-title>. <source>Semin Cancer Biol</source>
<volume>20</volume>: <fpage>353</fpage>&#x02013;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcancer.2010.10.005</pub-id>
<?supplied-pmid 20934515?><pub-id pub-id-type="pmid">20934515</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref107"><label>107</label><mixed-citation publication-type="journal"><name><surname>Loeb</surname><given-names>LA</given-names></name> (<year>2011</year>) <article-title>Human cancers express mutator phenotypes: origin, consequences and targeting</article-title>. <source>Nat Rev Cancer</source>
<volume>11</volume>: <fpage>450</fpage>&#x02013;<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1038/nrc3063</pub-id>
<?supplied-pmid 21593786?><pub-id pub-id-type="pmid">21593786</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref108"><label>108</label><mixed-citation publication-type="journal"><name><surname>Page</surname><given-names>KM</given-names></name>, <name><surname>Nowak</surname><given-names>MA</given-names></name> (<year>2002</year>) <article-title>Unifying evolutionary dynamics</article-title>. <source>J Theor Biol</source>
<volume>219</volume>: <fpage>93</fpage>&#x02013;<lpage>98</lpage>. <?supplied-pmid 12392978?><pub-id pub-id-type="pmid">12392978</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref109"><label>109</label><mixed-citation publication-type="book"><name><surname>Smolinski</surname><given-names>MS</given-names></name>, <name><surname>Hamburg</surname><given-names>MA</given-names></name>, <name><surname>Lederberg</surname><given-names>J</given-names></name>, editors (<year>2003</year>) <chapter-title>Microbial Threats to Health</chapter-title>
<source>Emergence, Detection and Response</source>. <publisher-loc>Washington DC</publisher-loc>: <publisher-name>The National Academies Press</publisher-name>.</mixed-citation></ref><ref id="pgen.1008271.ref110"><label>110</label><mixed-citation publication-type="journal"><name><surname>Rezelj</surname><given-names>VV</given-names></name>, <name><surname>Levi</surname><given-names>LI</given-names></name>, <name><surname>Vignuzzi</surname><given-names>M</given-names></name> (<year>2018</year>) <article-title>The defective component of viral populations</article-title>. <source>Curr Opin Virol</source>
<volume>33</volume>: <fpage>74</fpage>&#x02013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/j.coviro.2018.07.014</pub-id>
<?supplied-pmid 30099321?><pub-id pub-id-type="pmid">30099321</pub-id></mixed-citation></ref><ref id="pgen.1008271.ref111"><label>111</label><mixed-citation publication-type="journal"><name><surname>Geoghegan</surname><given-names>JL</given-names></name>, <name><surname>Holmes</surname><given-names>EC</given-names></name> (<year>2018</year>) <article-title>Evolutionary virology at 40</article-title>. <source>Genetics</source>
<volume>210</volume>:<fpage>1151</fpage>&#x02013;<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.118.301556</pub-id>
<?supplied-pmid 30523166?><pub-id pub-id-type="pmid">30523166</pub-id></mixed-citation></ref></ref-list></back></article>